All Stories

  1. Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity

    Article • Current Medicinal Chemistry, March 2024, Bentham Science Publishers

    Prof. Maciej Banach, Milad Shirvaliloo

  2. The Immunogenic Potential of PCSK9 Peptide Vaccine in Mice

    Article • Current Medicinal Chemistry, August 2023, Bentham Science Publishers

    Prof. Maciej Banach

  3. Impact of vitamin D receptor polymorphisms in selected metabolic disorders

    Article • Current Opinion in Clinical Nutrition & Metabolic Care, May 2023, Wolters Kluwer Health

    Prof. Maciej Banach

  4. Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials

    Article • Atherosclerosis, May 2023, Elsevier

    Prof. Maciej Banach

  5. Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program

    Article • Kardiologia Polska, April 2023, Polskie Towarzystwo Kardiologiczne

    Prof. Maciej Banach

  6. Age-Related Differences in the Role of Risk Factors for Ischemic Stroke

    Article • Neurology, April 2023, Wolters Kluwer Health

    Prof. Maciej Banach

  7. De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

    Article • European Journal of Internal Medicine, April 2023, Elsevier

    Prof. Maciej Banach

  8. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

    Article • Atherosclerosis, April 2023, Elsevier

    Prof. Maciej Banach

  9. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

    Article • Pharmacological Research, March 2023, Elsevier

    Professor Peter E. Penson, Dr Sonu Bhaskar, Professor Erkin Mirrakhimov, Prof. Maciej Banach

  10. On the Need for a Paradigm Change in the Valuation of Concrete with Waste Materials Based on the Example of Concrete with Crumb Rubber

    Article • Sustainability, February 2023, MDPI AG

    Prof. Maciej Banach

  11. Efficacy and safety of bempedoic acid in women with hypercholesterolemia: Pooled analyses from phase 3 trials

    Article • February 2023, Cold Spring Harbor Laboratory Press

    Prof. Maciej Banach

  12. Higher Plasma Levels of Valerate Produced by Gut Microbiota May Have a Beneficial Impact on Renal Function

    Article • Journal of the American Nutrition Association, February 2023, Taylor & Francis

    Prof. Maciej Banach

  13. In Reply: ACEI and ARB — Each Unique RAAS Inhibitors

    Article • Mayo Clinic Proceedings, February 2023, Elsevier

    Prof. Maciej Banach

  14. Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert ...

    Article • Experimental and Clinical Endocrinology & Diabetes, January 2023, Thieme Publishing Group

    Prof. Maciej Banach

  15. Which Statin is Best for the Kidneys?

    Article • Current Vascular Pharmacology, January 2023, Bentham Science Publishers

    Professor Peter E. Penson, Prof. Maciej Banach

  16. Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease prevention

    Article • Pharmacological Research, January 2023, Elsevier

    Prof. Maciej Banach

  17. Can We Use mTOR Inhibitors for COVID-19 Therapy?

    Article • Combinatorial Chemistry & High Throughput Screening, September 2022, Bentham Science Publishers

    Prof. Maciej Banach, Prof. MA Kamal, Professor Parames C Sil, Maryam Khayatkashani

  18. The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019

    Article • The Lancet Regional Health - Europe, May 2022, Elsevier

    Prof. Maciej Banach, Tommi Vasankari, Dr/ Adj Prof Vijay Kumar Chattu

  19. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Article • The Lancet Gastroenterology & Hepatology, April 2022, Elsevier

    Prof. Maciej Banach, Professor Yousef Khader, Andrew T. Olagunju, Dr Ashish D Badiye, Dr Ali Fatehizadeh, Dr. Ahmed I. Hasaballah, Turki Alanzi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Sumaira Mubarik

  20. Prognostic Impact of Hybrid Comprehensive Telerehabilitation Regarding Diastolic Dysfunction in Patients with Heart Failure with Reduced Ejection Fraction—Subanalysis of the TELEREH-HF Randomized Clinical Trial

    Article • Journal of Clinical Medicine, March 2022, MDPI AG

    Prof. Maciej Banach

  21. Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis

    Article • Nutrients, March 2022, MDPI AG

    Prof. Maciej Banach

  22. Contemporary Management of Dyslipidemia

    Article • Drugs, March 2022, Springer Science + Business Media

    Prof. Maciej Banach

  23. Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.

    Article • Archives of Medical Science, March 2022, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  24. The detrimental impact of elevated Ferritin to Iron ratio on in-hospital prognosis of patients with COVID-19

    Article • Expert Review of Molecular Diagnostics, March 2022, Taylor & Francis

    Prof. Maciej Banach

  25. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study

    Article • BMJ, March 2022, BMJ

    Prof. Maciej Banach, Dr Yuan-Pang Wang, Turki Alanzi, Getinet Ayano, Professor Yousef Khader, Andrew T. Olagunju, Dr Ashish D Badiye, Dr. Bolajoko O. Olusanya, Professor Erkin Mirrakhimov, Tommi Vasankari, Dr. Ahmed I. Hasaballah, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE

  26. Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications

    Article • Cardiovascular Research, March 2022, Oxford University Press (OUP)

    Prof. Maciej Banach

  27. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials

    Article • Journal of Clinical Lipidology, March 2022, Elsevier

    Prof. Maciej Banach

  28. Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases

    Article • Frontiers in Cardiovascular Medicine, February 2022, Frontiers

    Prof. Maciej Banach

  29. Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study

    Article • Frontiers in Cardiovascular Medicine, February 2022, Frontiers

    Prof. Maciej Banach

  30. Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly condition

    Article • European Journal of Preventive Cardiology, February 2022, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  31. Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia

    Article • Lipids in Health and Disease, February 2022, Springer Science + Business Media

    Prof. Maciej Banach

  32. Protective role of nutraceuticals against myocarditis

    Article • Biomedicine & Pharmacotherapy, February 2022, Elsevier

    Prof. Maciej Banach

  33. Relationship between Low-Density Lipoprotein Cholesterol, Lipid Lowering Agents and the Risk of Stroke: A meta-analysis of Observational studies (n=355,591) and Randomized Controlled Trials (n=165,988).

    Article • Archives of Medical Science, January 2022, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  34. Discordance between LDL-C and Apolipoprotein B Levels and Its Association with Renal Dysfunction: Insights from a Population-Based Study

    Article • Journal of Clinical Medicine, January 2022, MDPI AG

    Prof. Maciej Banach

  35. Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials

    Article • Nutrients, January 2022, MDPI AG

    Prof. Maciej Banach

  36. Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: a post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials

    Article • Diabetes Obesity and Metabolism, January 2022, Wiley

    Prof. Maciej Banach

  37. The Association between Coffee and Caffeine Consumption and Renal Function: Insight from Individual-Level Data, Mendelian Randomization, and Meta-Analysis

    Article • Archives of Medical Science, December 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  38. Implications of the 2021 ESC Cardiovascular Risk Classification among 283,000 European Immigrants Living in a Low-Risk Region: A Population-Based Analysis in Catalonia

    Article • Archives of Medical Science, December 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  39. Sleep Duration May Not Have Any Effect on The Risk of Stroke: Insights from Mendelian Randomization and Prospective Cohort Studies

    Article • Archives of Medical Science, November 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  40. Extreme cardiovascular risk—do we need a new risk category?

    Article • European Heart Journal, November 2021, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  41. Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study

    Article • Rheumatology International, November 2021, Springer Science + Business Media

    Professor Peter E. Penson, Prof. Maciej Banach

  42. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

    Article • Archives of Medical Science, November 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  43. A systematic review and meta-analysis on the effects of statins on pregnancy outcomes

    Article • Atherosclerosis, November 2021, Elsevier

    Prof. Maciej Banach

  44. Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE

    Article • Archives of Medical Science, October 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  45. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection

    Article • Lipids in Health and Disease, October 2021, Springer Science + Business Media

    Prof. Maciej Banach

  46. Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel

    Article • Journal of Clinical Medicine, October 2021, MDPI AG

    Prof. Maciej Banach

  47. The International Lipid Expert Panel (ILEP)—the role of ‘optimal’ collaboration in the effective diagnosis and treatment of lipid disorders

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Prof. Maciej Banach

  48. Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study

    Article • Atherosclerosis, October 2021, Elsevier

    Prof. Maciej Banach

  49. Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study

    Article • Journal of Clinical Medicine, September 2021, MDPI AG

    Professor Peter E. Penson, Prof. Maciej Banach

  50. Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis

    Article • BioMed Research International, September 2021, Hindawi Publishing Corporation

    Prof. Maciej Banach

  51. Harnessing polyphenol power by targeting eNOS for vascular diseases

    Article • Critical Reviews in Food Science and Nutrition, September 2021, Taylor & Francis

    Prof. Maciej Banach

  52. Clinical Features of Familial Hypercholesterolemia in Children and Adults in EAS-FHSC Regional Center for Rare Diseases in Poland

    Article • Journal of Clinical Medicine, September 2021, MDPI AG

    Professor Peter E. Penson, Prof. Maciej Banach

  53. The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis

    Article • Current Medicinal Chemistry, September 2021, Bentham Science Publishers

    Prof. Maciej Banach

  54. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status

    Article • The Lancet Infectious Diseases, September 2021, Elsevier

    Mr. Amadou Barrow, Prof. Maciej Banach, Professor Yousef Khader, Andrew T. Olagunju, Dr. Jitendra Kumar Singh, Dr Saurabh Mehta, Dr Fakher Rahim, Asrat Arja Wolde, Dr. Ahmed I. Hasaballah, Dr/ Adj Prof Vijay Kumar Chattu

  55. Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry

    Article • Atherosclerosis, September 2021, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  56. The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis

    Article • Seminars in Cancer Biology, September 2021, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  57. Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice

    Article • Nutrients, August 2021, MDPI AG

    Prof. Maciej Banach, Professor Peter E. Penson

  58. Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey

    Article • Journal of Clinical Medicine, August 2021, MDPI AG

    Prof. Maciej Banach

  59. Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosis

    Article • Archives of Medical Science, August 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  60. Are risk-based LDL-c goals achieved in primary and secondary care in central and Eastern Europe? comparison with other Europe regions from the DA VINCI observational study

    Article • Atherosclerosis, August 2021, Elsevier

    Prof. Maciej Banach

  61. Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension

    Article • Journal of Personalized Medicine, July 2021, MDPI AG

    Prof. Maciej Banach

  62. Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors - analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.

    Article • Archives of Medical Science, July 2021, Termedia Sp. z.o.o.

    Professor Peter E. Penson, Prof. Maciej Banach

  63. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies

    Article • BMC Medicine, June 2021, Springer Science + Business Media

    Prof. Maciej Banach

  64. Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations

    Article • European Heart Journal, June 2021, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  65. Is COVID-19 Another Case of Obesity Paradox? - Results from An International Ecological Study on behalf of the REPROGRAM Consortium Obesity

    Article • Archives of Medical Science, May 2021, Termedia Sp. z.o.o.

    Dr Sonu Bhaskar, Prof. Maciej Banach

  66. COVID-19 and cardiovascular complications – the preliminary results of the LATE-COVID study

    Article • Archives of Medical Science, May 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  67. Serum anti-inflammatory and inflammatory markers have no causal impact on telomere length: a Mendelian randomization study

    Article • Archives of Medical Science, May 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  68. Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications

    Article • ESC Heart Failure, May 2021, Wiley

    Prof. Maciej Banach

  69. Targeting AMPK by Statins: A Potential Therapeutic Approach

    Article • Drugs, May 2021, Springer Science + Business Media

    Prof. Maciej Banach

  70. Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

    Article • Atherosclerosis, May 2021, Elsevier

    Prof. Maciej Banach

  71. Antiarrhythmic effect of 9-week hybrid cardiac telerehabilitation - subanalysis of the TELEREHabilitation in Heart Failure patients - TELEREH-HF randomized clinical trial

    Article • EP Europace, May 2021, Oxford University Press (OUP)

    Prof. Maciej Banach

  72. Omega-6 fatty acids and the Risk of Cardiovascular Disease: Insights from a Systematic Review and Meta-Analysis of Randomized Controlled Trials and a Mendelian Randomization Study.

    Article • Archives of Medical Science, April 2021, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  73. Foam Cells as Therapeutic Targets in Atherosclerosis with a Focus on the Regulatory Roles of Non-Coding RNAs

    Article • International Journal of Molecular Sciences, March 2021, MDPI AG

    Prof. Maciej Banach

  74. Α higher ratio of serum uric acid to serum creatinine could predict the risk of total and cause specific mortality- insight from a US national survey

    Article • International Journal of Cardiology, March 2021, Elsevier

    Prof. Maciej Banach

  75. Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice

    Article • Irish Journal of Medical Science (1971 -), February 2021, Springer Science + Business Media

    Prof. Maciej Banach

  76. Renal Denervation for Uncontrolled and Resistant Hypertension: Systematic Review and Network Meta-Analysis of Randomized Trials

    Article • Journal of Clinical Medicine, February 2021, MDPI AG

    Prof. Maciej Banach

  77. Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel

    Article • Diabetes Research and Clinical Practice, February 2021, Elsevier

    Prof. Maciej Banach

  78. An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial

    Article • ESC Heart Failure, February 2021, Wiley

    Prof. Maciej Banach

  79. Effects of statins on mitochondrial pathways

    Article • Journal of Cachexia Sarcopenia and Muscle, January 2021, Wiley

    Prof. Maciej Banach

  80. Drucebo effect – the challenge we should all definitely face!

    Article • Archives of Medical Science, January 2021, Termedia Sp. z.o.o.

    Professor Peter E. Penson, Prof. Maciej Banach

  81. Lipid-lowering therapies: Better together

    Article • Atherosclerosis, January 2021, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  82. Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants

    Article • Annals of Medicine, January 2021, Taylor & Francis

    Prof. Maciej Banach

  83. Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study

    Article • European Journal of Preventive Cardiology, November 2020, Oxford University Press (OUP)

    Prof. Maciej Banach

  84. New trends in the pharmacological intervention of PPARs in obesity: Role of natural and synthetic compounds_

    Article • Current Medicinal Chemistry, November 2020, Bentham Science Publishers

    Professor Luciano Saso, Prof. Maciej Banach, Ana Sanches Silva, Dr Suowen Xu, Dr Seyed Mohammad Nabavi, Antoni Sureda

  85. Longer sleep duration may negatively affect renal function

    Article • International Urology and Nephrology, September 2020, Springer Science + Business Media

    Prof. Maciej Banach

  86. Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19

    Article • Angiology, August 2020, SAGE Publications

    Prof. Maciej Banach

  87. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic

    Article • Pharmacological Research, August 2020, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  88. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis

    Article • PLoS Medicine, July 2020, PLOS

    Professor Peter E. Penson, Dr Arrigo FG CICERO, Prof. Maciej Banach, Professor Erkin Mirrakhimov

  89. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia

    Article • JAMA Cardiology, July 2020, American Medical Association (AMA)

    Prof. Maciej Banach

  90. Cholesterol in Relation to COVID-19: Should We Care about It?

    Article • Journal of Clinical Medicine, June 2020, MDPI AG

    Prof. Maciej Banach

  91. Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, June 2020, Elsevier

    Turki Alanzi, Dr Senthilkumar Balakrishnan, Prof. Maciej Banach, Dr Yuan-Pang Wang, Dr Senbagam Duraisamy, Dr Shariful Islam, ED Doris V. Ortega-Altamirano, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Melkamu Merid Mengesha , Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Getinet Ayano, Professor HESHAM M. AL-MEKHLAFI, Professor Yousef Khader, Andrew T. Olagunju, Dr Bereket Duko , Prof Joel Msafiri Francis, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Professor Erkin Mirrakhimov, Gebrekiros Gebremichael, Mr Nejimu Biza Zepro, Dr. Ahmed I. Hasaballah, Dr/ Adj Prof Vijay Kumar Chattu

  92. Epigenetics in atherosclerosis: key features and therapeutic implications

    Article • Expert Opinion on Therapeutic Targets, June 2020, Taylor & Francis

    Prof. Maciej Banach

  93. Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

    Article • Clinical Reviews in Allergy & Immunology, May 2020, Springer Science + Business Media

    Prof. Maciej Banach

  94. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017

    Article • Injury Prevention, April 2020, BMJ

    Dr. Asres Bedaso Tilahune, Mr Raimundas Lunevicius, Dr Garumma TOLU FEYISSA, Prof. Maciej Banach, Tommi Vasankari, Professor Yousef Khader, Kathryn H. Jacobsen, Prof.Dr. Adnan Kisa, Amrit Banstola, Melkamu Merid Mengesha , Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Getinet Ayano, Andrew T. Olagunju, Dr Shariful Islam, Dr marek majdan, Dr Aidin Abedi, Prof Joel Msafiri Francis, Dr Fakher Rahim, Dr Ashish D Badiye, Professor Erkin Mirrakhimov, Professor Ashraf Fawzy Nabhan, Dr Vahid Rashedi, Dr/ Adj Prof Vijay Kumar Chattu

  95. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

    Article • Nature Medicine, April 2020, Springer Science + Business Media

    Mr Zelalem Alamrew Anteneh, Baye Dagnew, Turki Alanzi, Dr Garumma TOLU FEYISSA, Dr Senthilkumar Balakrishnan, Prof. Maciej Banach, Tommi Vasankari, Mr. Habtamu Kebebe Kasaye, Dr Yuan-Pang Wang, Professor Yousef Khader, Dr Shariful Islam, Prof.Dr. Adnan Kisa, Dr Amin Mousavi Khaneghah, Professor Stefan Lorkowski, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Professor HESHAM M. AL-MEKHLAFI, Andrew T. Olagunju, Dr Bereket Duko , Professor Alina Rodriguez, Prof Joel Msafiri Francis, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Mr. Anemaw A. Asrat, Dr Ashish D Badiye, Dr Nelsensius Klau Fauk, Dr. Bolajoko O. Olusanya, Professor Erkin Mirrakhimov, Rajaa Al-Raddadi, Gebrekiros Gebremichael, Dr Vahid Rashedi, Mr Nejimu Biza Zepro, Professor ORISH EBERE ORSAKWE, Dr. Ahmed I. Hasaballah, Dr/ Adj Prof Vijay Kumar Chattu, PhD. Carla Sofia FARINHA

  96. Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial

    Article • Journal of Arrhythmia, April 2020, Wiley

    Prof. Maciej Banach

  97. An overview of statin-induced myopathy and perspectives for the future

    Article • Expert Opinion on Drug Safety, April 2020, Taylor & Francis

    Prof. Maciej Banach

  98. Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort

    Article • Lipids in Health and Disease, April 2020, Springer Science + Business Media

    Prof. Maciej Banach

  99. Egg Intake: Getting the Balance Right!

    Article • Angiology, April 2020, SAGE Publications

    Prof. Maciej Banach

  100. Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study

    Article • Clinical Nutrition, April 2020, Elsevier

    Prof. Maciej Banach

  101. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3

    Article • The Lancet, April 2020, Elsevier

    Prof. Maciej Banach, Tommi Vasankari, Dr Shariful Islam, Prof.Dr. Adnan Kisa, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Andrew T. Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Professor Erkin Mirrakhimov, Dr/ Adj Prof Vijay Kumar Chattu, Dr Hoa Do

  102. Effect of Evolocumab on Non‐High‐Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies

    Article • Journal of the American Heart Association, March 2020, Wolters Kluwer Health

    Prof. Maciej Banach

  103. Changes in disease burden in Poland between 1990–2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017

    Article • PLoS ONE, March 2020, PLOS

    Prof. Maciej Banach, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE

  104. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels

    Article • Trends in Cardiovascular Medicine, March 2020, Elsevier

    Prof. Maciej Banach

  105. A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS EVALUATING RENAL DENERVATION FOR UNCONTROLLED AND RESISTANT HYPERTENSION

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Prof. Maciej Banach

  106. Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies

    Article • Atherosclerosis, March 2020, Elsevier

    Prof. Maciej Banach

  107. BEMPEDOIC ACID EFFICACY AND SAFETY IN HIGH CVD RISK PATIENTS TREATED WITH OR WITHOUT EZETIMIBE: POOLED ANALYSIS OF 4 PHASE 3 CLINICAL TRIALS

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Prof. Maciej Banach

  108. EFFICACY AND SAFETY OF ALIROCUMAB IN A REAL-LIFE SETTING IN PATIENTS WITH OR WITHOUT FAMILIAL HYPERCHOLESTEROLEMIA: THE ODYSSEY APPRISE STUDY

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Prof. Maciej Banach

  109. Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure

    Article • JAMA Cardiology, March 2020, American Medical Association (AMA)

    Prof. Maciej Banach

  110. FACTORS THAT INFLUENCE BEMPEDOIC ACID-MEDIATED REDUCTIONS IN HIGH-SENSITIVITY C-REACTIVE PROTEIN: ANALYSIS OF POOLED PATIENT-LEVEL DATA FROM PHASE 3 CLINICAL TRIALS

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Prof. Maciej Banach

  111. Incretins and microRNAs: Interactions and physiological relevance

    Article • Pharmacological Research, March 2020, Elsevier

    Prof. Maciej Banach

  112. High‐Sensitivity C‐Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study

    Article • Journal of the American Heart Association, February 2020, Wolters Kluwer Health

    Prof. Maciej Banach

  113. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, February 2020, Elsevier

    Daniel Asmelash , Zewudu Andualem , Kaleab Alemayehu Zewdie, Prof. Maciej Banach, Professor Yousef Khader, Dr Shariful Islam, Prof.Dr. Adnan Kisa, Andrew T. Olagunju, Professor Erkin Mirrakhimov, Rajaa Al-Raddadi

  114. LCZ696 (sacubitril/valsartan) for patients with heart failure

    Article • Cochrane Database of Systematic Reviews, January 2020, Wiley

    Prof. Maciej Banach

  115. Apolipoprotein B/Apolipoprotein A-I Ratio Is a Better Predictor of Cancer Mortality Compared with C-Reactive Protein: Results from Two Multi-Ethnic US Populations

    Article • Journal of Clinical Medicine, January 2020, MDPI AG

    Prof. Maciej Banach

  116. Epidemiology of facial fractures: incidence, prevalence and years lived with disability estimates from the Global Burden of Disease 2017 study

    Article • Injury Prevention, January 2020, BMJ

    Prof. Maciej Banach, Professor Yousef Khader, Dr marek majdan

  117. 2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders

    Article • Archives of Medical Science, January 2020, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  118. Effects of immunisation against PCSK9 in mice bearing melanoma

    Article • Archives of Medical Science, January 2020, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  119. Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2

    Article • Archives of Medical Science, January 2020, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  120. Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic

    Article • Archives of Medical Science, January 2020, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  121. Low-carbohydrate diet: forget restriction, replace with balance!

    Article • European Heart Journal, December 2019, Oxford University Press (OUP)

    Prof. Maciej Banach

  122. Impact of serum 25-hydroxyvitamin D 25(OH) on telomere attrition: A Mendelian Randomization study

    Article • Clinical Nutrition, December 2019, Elsevier

    Prof. Maciej Banach

  123. Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis

    Article • BMC Medicine, December 2019, Springer Science + Business Media

    Prof. Maciej Banach

  124. Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies

    Article • Angiology, November 2019, SAGE Publications

    Dr Arrigo FG CICERO, Prof. Maciej Banach

  125. Ca2+ Flux: Searching for a Role in Efferocytosis of Apoptotic Cells in Atherosclerosis

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Prof. Maciej Banach

  126. Statins and Lp(a): do not make perfect the enemy of excellent

    Article • European Heart Journal, November 2019, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  127. Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study

    Article • Nutrients, October 2019, MDPI AG

    Prof. Maciej Banach, Giuseppe Antonio Malfa, Prof. Antonio Magan-Fernandez

  128. Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units

    Article • Journal of Clinical Medicine, October 2019, MDPI AG

    Prof. Maciej Banach

  129. Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology

    Article • Disease Markers, September 2019, Hindawi Publishing Corporation

    Prof. Maciej Banach

  130. A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome

    Article • Drug Discovery Today, September 2019, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  131. Genetic testing in familial hypercholesterolaemia: What does it add?

    Article • European Journal of Preventive Cardiology, August 2019, SAGE Publications

    Prof. Maciej Banach, Professor Peter E. Penson

  132. Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease

    Article • Expert Opinion on Pharmacotherapy, August 2019, Taylor & Francis

    Prof. Maciej Banach

  133. Modulation of microRNAs by aspirin in cardiovascular disease

    Article • Trends in Cardiovascular Medicine, August 2019, Elsevier

    Prof. Maciej Banach

  134. Methotrexate for Cardiovascular Risk Reduction: The Right Choice?

    Article • Angiology, June 2019, SAGE Publications

    Prof. Maciej Banach

  135. A review of gene- and cell-based therapies for familial hypercholesterolemia

    Article • Pharmacological Research, May 2019, Elsevier

    Prof. Maciej Banach

  136. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent

    Article • The Journal of Nutritional Biochemistry, April 2019, Elsevier

    Prof. Maciej Banach

  137. A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study

    Article • The Journal of Nutritional Biochemistry, March 2019, Elsevier

    Prof. Maciej Banach

  138. ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials

    Article • Expert Opinion on Pharmacotherapy, February 2019, Taylor & Francis

    Dr Massimiliano Ruscica, Prof. Maciej Banach

  139. Role of Geriatric Syndromes in the Management of Atrial Fibrillation in Older Adults: A Narrative Review

    Article • Journal of the American Medical Directors Association, February 2019, Elsevier

    Prof. Maciej Banach

  140. Dietary natural products as emerging lipoprotein(a)‐lowering agents

    Article • Journal of Cellular Physiology, January 2019, Wiley

    Prof. Maciej Banach

  141. What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcomes trials?

    Article • Cardiovascular Research, January 2019, Oxford University Press (OUP)

    Prof. Maciej Banach, Professor Peter E. Penson

  142. Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes – Data from the TERCET registry with 19,287 patients

    Article • Pharmacological Research, January 2019, Elsevier

    Prof. Maciej Banach

  143. A systematic review and meta-analysis of clinical trials investigating the effects of flaxseed supplementation on plasma C-reactive protein concentrations

    Article • Archives of Medical Science, January 2019, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  144. High-Density Lipoprotein Components and Functionality in Cancer: State-of-the-Art

    Article • Trends in Endocrinology and Metabolism, January 2019, Elsevier

    Prof. Maciej Banach

  145. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016

    Article • New England Journal of Medicine, December 2018, New England Journal of Medicine (NEJM/MMS)

    Denny John, Prof. Maciej Banach, Professor Amanda G Thrift, Tommi Vasankari, Professor Yousef Khader, Professor Stefan Lorkowski, Andrew T. Olagunju, Rajaa Al-Raddadi

  146. Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth

    Article • Oxidative Medicine and Cellular Longevity, December 2018, Hindawi Publishing Corporation

    Prof. Maciej Banach, Wojciech Horzelski

  147. Link between plasma trans-fatty acid and fatty liver is moderated by adiposity

    Article • International Journal of Cardiology, December 2018, Elsevier

    Prof. Maciej Banach

  148. Consumption of dairy product and its association with total and cause specific mortality – A population-based cohort study and meta-analysis

    Article • Clinical Nutrition, December 2018, Elsevier

    Prof. Maciej Banach

  149. Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score

    Article • Data in Brief, December 2018, Elsevier

    Prof. Maciej Banach

  150. Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials

    Article • Scientific Reports, December 2018, Springer Science + Business Media

    Prof. Maciej Banach

  151. MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy

    Article • Trends in Pharmacological Sciences, November 2018, Elsevier

    Mohammad Mohajeri, Prof. Maciej Banach

  152. Natural products for targeted therapy in precision medicine

    Article • Biotechnology Advances, November 2018, Elsevier

    Prof. Maciej Banach

  153. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, A/Prof Chris Lonsdale, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Andre Luiz Sena Guimaraes, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Professor Amanda G Thrift, Mr Raimundas Lunevicius, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Andrew T. Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi

  154. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Andrew T. Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Professor Ashraf Fawzy Nabhan, DR Lambert Tetteh Appiah, Dr/ Adj Prof Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi

  155. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Mr Raimundas Lunevicius, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Andrew T. Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Professor Ashraf Fawzy Nabhan, Dr/ Adj Prof Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi

  156. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Amrit Banstola, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Andrew T. Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Tommi Vasankari, Professor Ashraf Fawzy Nabhan, Dr/ Adj Prof Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi

  157. Measuring progress of the health-related Sustainable Development Goals for 195 countries

    Article • The Lancet, November 2018, Elsevier

    Kathryn H. Jacobsen, Mr. Tara Ballav Adhikari, ED Doris V. Ortega-Altamirano, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Andre Luiz Sena Guimaraes, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Professor Amanda G Thrift, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Amrit Banstola, Professor Stefan Lorkowski, Professor HESHAM M. AL-MEKHLAFI, Andrew T. Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Professor Ashraf Fawzy Nabhan, DR Lambert Tetteh Appiah, Dr/ Adj Prof Vijay Kumar Chattu, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi

  158. Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults

    Article • International Journal of Cardiology, November 2018, Elsevier

    Prof. Maciej Banach

  159. Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey

    Article • Atherosclerosis, November 2018, Elsevier

    Prof. Maciej Banach

  160. Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Undergoing Cardioversion of Atrial Fibrillation (From ENSURE-AF)

    Article • The American Journal of Cardiology, November 2018, Elsevier

    Prof. Maciej Banach

  161. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, November 2018, Elsevier

    Mr. Tara Ballav Adhikari, A/Prof Chris Lonsdale, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Dr Andre Luiz Sena Guimaraes, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Professor Amanda G Thrift, Mr Raimundas Lunevicius, Tommi Vasankari, Professor Yousef Khader, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Amrit Banstola, Professor Stefan Lorkowski, Andrew T. Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi

  162. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Article • The Lancet, November 2018, Elsevier

    Mr. Tara Ballav Adhikari, Dr. Paul E Kilgore, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Shariful Islam, Farhad Shokraneh, Dr Gebre Teklemariam Demoz, Dr Yuan-Pang Wang, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Garumma TOLU FEYISSA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Mr. Aklilu Abrham, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Professor Stefan Lorkowski, Melkamu Merid Mengesha , Andrew T. Olagunju, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Mr. Alex Yeshaneh, Rajaa Al-Raddadi, Dr Olayinka Stephen Ilesanmi, Dr. Mohammad Hossein Khosravi

  163. Phytol: A review of biomedical activities

    Article • Food and Chemical Toxicology, November 2018, Elsevier

    Dr Amr El-Demerdash, Prof. Maciej Banach, Dr. Utpal Kumar Karmakar

  164. Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials

    Article • BMJ Open, November 2018, BMJ

    Prof. Maciej Banach

  165. Inverse association between serum antioxidant levels and inflammatory markers is moderated by adiposity: a report based on a large representative population sample of American adults

    Article • British Journal Of Nutrition, October 2018, Cambridge University Press

    Prof. Maciej Banach

  166. A higher ratio of refined grain to whole grain is associated with a greater likelihood of chronic kidney disease: a population-based study

    Article • British Journal Of Nutrition, October 2018, Cambridge University Press

    Prof. Maciej Banach

  167. Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions

    Article • Journal of Cachexia Sarcopenia and Muscle, October 2018, Wiley

    Prof. Maciej Banach, Professor Peter E. Penson

  168. Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?

    Article • Expert Opinion on Pharmacotherapy, October 2018, Taylor & Francis

    Prof. Maciej Banach, Professor Maciej Banach, Professor Peter E. Penson

  169. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study

    Article • Atherosclerosis, October 2018, Elsevier

    Prof. Maciej Banach

  170. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Article • Atherosclerosis, October 2018, Elsevier

    Prof. Maciej Banach, Professor Erkin Mirrakhimov

  171. The Yin and Yang of carbon nanomaterials in atherosclerosis

    Article • Biotechnology Advances, October 2018, Elsevier

    Prof. Maciej Banach, behzad behnam

  172. Application of nanotechnology to improve the therapeutic benefits of statins

    Article • Drug Discovery Today, October 2018, Elsevier

    Prof. Maciej Banach

  173. Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials

    Article • Annals of Medicine, September 2018, Taylor & Francis

    Luis E. Simental-Mendía, Prof. Maciej Banach

  174. Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations

    Article • BMC Medicine, September 2018, Springer Science + Business Media

    Prof. Maciej Banach

  175. Adiposity mediates the association between whole grain consumption, glucose homeostasis and insulin resistance: findings from the US NHANES

    Article • Lipids in Health and Disease, September 2018, Springer Science + Business Media

    Prof. Maciej Banach

  176. Effect of statins on toll-like receptors: a new insight to pleiotropic effects

    Article • Pharmacological Research, September 2018, Elsevier

    Prof. Maciej Banach

  177. Dietary inflammatory index and cardiometabolic risk in US adults

    Article • Atherosclerosis, September 2018, Elsevier

    Prof. Maciej Banach

  178. PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results?

    Article • Journal of Clinical Lipidology, September 2018, Elsevier

    Prof. Maciej Banach

  179. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  180. Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    Prof. Maciej Banach

  181. Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function

    Article • Clinical Research in Cardiology, August 2018, Springer Science + Business Media

    Prof. Maciej Banach

  182. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases

    Article • Journal of Cellular Physiology, August 2018, Wiley

    Prof. Maciej Banach

  183. Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study

    Article • Cardiovascular Research, August 2018, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  184. Alcohol use and attributable disease burden in 195

    Article • The Lancet, August 2018, Elsevier

    Dr Yuan-Pang Wang, Prof. Maciej Banach, Mr. Tara Ballav Adhikari, ED Doris V. Ortega-Altamirano, Ebrahim M. Yimer, Professor Erkin Mirrakhimov, Dr Shariful Islam, Dr Gebre Teklemariam Demoz, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Dr Azmeraw Amare, Professor Yousef Khader, Prof.Dr. Adnan Kisa, Andrew T. Olagunju, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Dr. Bolajoko O. Olusanya, Dr Olayinka Stephen Ilesanmi

  185. Modulation of heat shock proteins by statins

    Article • Pharmacological Research, August 2018, Elsevier

    Prof. Maciej Banach

  186. Incidence of familial hypercholesterolemia in patients from the tercet registry

    Article • Atherosclerosis, August 2018, Elsevier

    Prof. Maciej Banach

  187. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”

    Article • Atherosclerosis, August 2018, Elsevier

    Prof. Maciej Banach

  188. Novel Therapeutic Targets for Managing Dyslipidemia

    Article • Trends in Pharmacological Sciences, August 2018, Elsevier

    Prof. Maciej Banach

  189. The optimal time of day for statin administration

    Article • Current Opinion in Lipidology, August 2018, Wolters Kluwer Health

    Prof. Maciej Banach

  190. Serum lipophilic antioxidants levels are associated with leucocyte telomere length among US adults

    Article • Lipids in Health and Disease, July 2018, Springer Science + Business Media

    Prof. Maciej Banach

  191. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines

    Article • Circulation, July 2018, Wolters Kluwer Health

    Prof. Maciej Banach

  192. Decompensated Heart Failure and Renal Failure: What Is the Current Evidence?

    Article • Current Heart Failure Reports, July 2018, Springer Science + Business Media

    Prof. Maciej Banach

  193. High density lipoprotein cholesterol and cancer: Marker or causative?

    Article • Progress in Lipid Research, July 2018, Elsevier

    Prof. Maciej Banach

  194. The Role of Nutraceuticals in Statin Intolerant Patients

    Article • Journal of the American College of Cardiology, July 2018, Elsevier

    Prof. Maciej Banach

  195. Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials

    Article • Annals of Medicine, June 2018, Taylor & Francis

    Luis E. Simental-Mendía, Fabrizio Montecucco, Dr Federico Carbone, Prof. Maciej Banach

  196. Leptin, cardiovascular diseases and type 2 diabetes mellitus

    Article • Acta Pharmacologica Sinica, June 2018, Springer Science + Business Media

    Prof. Maciej Banach

  197. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories

    Article • The Lancet, June 2018, Elsevier

    Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Dr Shariful Islam, Professor Stefan Lorkowski, Professor Erkin Mirrakhimov, Prof Richard G White, Dr Yuan-Pang Wang, Prof. Maciej Banach, Mr. Tara Ballav Adhikari, ED Doris V. Ortega-Altamirano, Ebrahim M. Yimer, Dr Gebre Teklemariam Demoz, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr Srinivas Goli, Prof.Dr. Adnan Kisa, Amrit Banstola, Netsanet Asseffa, Andrew T. Olagunju, Dr Md Nuruzzaman Khan, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi, Dr Olayinka Stephen Ilesanmi

  198. Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials

    Article • Pharmacological Research, June 2018, Elsevier

    Prof. Maciej Banach, Mario Simental-Mendía

  199. Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease

    Article • Kidney International, June 2018, Elsevier

    Prof. Maciej Banach

  200. Evaluation of dyslipidaemia and the impact of hypolipidemic therapy on prognosis in high and very high risk patients through the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) Registry

    Article • Pharmacological Research, June 2018, Elsevier

    Prof. Maciej Banach

  201. From meta-analysis to Cochrane reviews

    Article • Journal of Cachexia Sarcopenia and Muscle, June 2018, Wiley

    Prof. Maciej Banach

  202. Higher dietary acid load is associated with higher likelihood of peripheral arterial disease among American adults

    Article • Journal of Diabetes and its Complications, June 2018, Elsevier

    Prof. Maciej Banach

  203. Phase 3 Evaluation of Bempedoic Acid Added to Ezetimibe in Patients with Elevated LDL-cholesterol Receiving No Greater Than Low Dose Statins: CLEAR Tranquility

    Article • Atherosclerosis Supplements, June 2018, Elsevier

    Prof. Maciej Banach

  204. PCSK9 genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization study

    Article • May 2018, Cold Spring Harbor Laboratory Press

    Prof. Maciej Banach

  205. Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?

    Article • International Urology and Nephrology, May 2018, Springer Science + Business Media

    Prof. Maciej Banach

  206. Effect of Metformin on Plasma Fibrinogen Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

    Article • Current Pharmaceutical Design, May 2018, Bentham Science Publishers

    Prof. Maciej Banach

  207. Resveratrol effect on patients with non-alcoholic fatty liver disease: A matter of dose and treatment length

    Article • Diabetes Obesity and Metabolism, May 2018, Wiley

    Federica Fogacci, Prof. Maciej Banach

  208. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015

    Article • The Lancet, May 2018, Elsevier

    Denny John, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Mr. Tara Ballav Adhikari, Ebrahim M. Yimer, Dr Srinivas Goli, Amrit Banstola

  209. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40

    Article • The Lancet, May 2018, Elsevier

    Denny John, Maysaa El Sayed Zaki, Professor Erkin Mirrakhimov, Prof. Maciej Banach, Ebrahim M. Yimer, Dr Srinivas Goli, Amrit Banstola

  210. Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials

    Article • Journal of Clinical Lipidology, May 2018, Elsevier

    Prof. Maciej Banach, Dr Massimiliano Ruscica

  211. Statin Intolerance

    Article • Cardiology Clinics, May 2018, Elsevier

    Prof. Maciej Banach

  212. The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review

    Article • Expert Opinion on Investigational Drugs, April 2018, Taylor & Francis

    Prof. Maciej Banach

  213. The impact of nuts consumption on glucose/insulin homeostasis and inflammation markers mediated by adiposity factors among American adults

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Prof. Maciej Banach

  214. Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases

    Article • Current Pharmaceutical Design, April 2018, Bentham Science Publishers

    Dr Arrigo FG CICERO, Giuseppe Lippi, Prof. Maciej Banach

  215. Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure

    Article • Trends in Pharmacological Sciences, April 2018, Elsevier

    Prof. Maciej Banach

  216. Botanicals and phytochemicals active on cognitive decline: The clinical evidence

    Article • Pharmacological Research, April 2018, Elsevier

    Prof. Maciej Banach

  217. Evaluation of a dimeric-cRGD peptide for targeted PET-CT imaging of peripheral angiogenesis in diabetic mice

    Article • Scientific Reports, March 2018, Springer Science + Business Media

    Prof. Maciej Banach

  218. Novel drugs for heart rate control in heart failure

    Article • Heart Failure Reviews, March 2018, Springer Science + Business Media

    Prof. Maciej Banach

  219. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants

    Article • International Journal of Epidemiology, March 2018, Oxford University Press (OUP)

    Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr Andre Luiz Sena Guimaraes, Giovanni Veronesi, Dr. Anwar Mahmoud Batieha, Professor Yousef Khader, Axel Carlsson, DR Bontha Veerraju Babu, Rajaa Al-Raddadi

  220. Association between plasma trans fatty acids concentrations and leucocyte telomere length in US adults

    Article • European Journal of Clinical Nutrition, March 2018, Springer Science + Business Media

    Prof. Maciej Banach

  221. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland

    Article • Atherosclerosis, March 2018, Elsevier

    Prof. Maciej Banach

  222. The link between insulin resistance parameters and serum uric acid is mediated by adiposity

    Article • Atherosclerosis, March 2018, Elsevier

    Prof. Maciej Banach

  223. Bleeding in advanced CKD patients on antithrombotic medication – A critical appraisal

    Article • Pharmacological Research, March 2018, Elsevier

    Prof. Maciej Banach

  224. IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL

    Article • Journal of the American College of Cardiology, March 2018, Elsevier

    Prof. Maciej Banach

  225. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance

    Article • Journal of Diabetes and its Complications, March 2018, Elsevier

    Prof. Maciej Banach

  226. Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Article • Drugs, February 2018, Springer Science + Business Media

    Prof. Maciej Banach

  227. Effects of coenzyme Q10 supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials

    Article • Pharmacological Research, February 2018, Elsevier

    Prof. Maciej Banach

  228. Management of Statin Intolerance in 2018: Still More Questions Than Answers

    Article • American Journal of Cardiovascular Drugs, January 2018, Springer Science + Business Media

    Prof. Maciej Banach

  229. Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview

    Article • Archives of Medical Science, January 2018, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  230. Complications of Diabetes 2017

    Article • Journal of Diabetes Research, January 2018, Hindawi Publishing Corporation

    Prof. Maciej Banach

  231. Effect of magnesium supplements on serum C-reactive protein: a systematic review and meta-analysis

    Article • Archives of Medical Science, January 2018, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  232. Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis

    Article • Journal of Clinical Lipidology, January 2018, Elsevier

    Prof. Maciej Banach

  233. HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions

    Article • Drug Discovery Today, January 2018, Elsevier

    Prof. Maciej Banach

  234. Hypercholesterolaemia – practical information for non-specialists

    Article • Archives of Medical Science, January 2018, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  235. Natural approaches in metabolic syndrome management

    Article • Archives of Medical Science, January 2018, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  236. Prevalence of childhood and adolescent overweight and obesity in Asian countries: a systematic review and meta-analysis

    Article • Archives of Medical Science, January 2018, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  237. Association Between Plasma Trans-Fatty Acid Concentrations and Measures of Glucose Homeostasis and Cardiovascular Risk Factors in Adults in NHANES 1999-2000

    Article • Angiology, December 2017, SAGE Publications

    Prof. Maciej Banach

  238. Adhering to the principles of clinical pharmacology - the correct fixed combinations of antihypertensive drugs

    Article • Expert Review of Clinical Pharmacology, December 2017, Taylor & Francis

    Prof. Maciej Banach

  239. Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications

    Article • Medical Oncology, December 2017, Springer Science + Business Media

    Prof. Maciej Banach

  240. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

    Article • The Lancet, December 2017, Elsevier

    Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr. Anwar Mahmoud Batieha, Dr. Stevo Popovic, Dr Andre Luiz Sena Guimaraes, Prof. Catherine Kyobutungi, Giovanni Veronesi, Francesco Panza, Professor Yousef Khader, Axel Carlsson, DR Bontha Veerraju Babu, Rajaa Al-Raddadi

  241. Dietary patterns, plasma vitamins and Trans fatty acids are associated with peripheral artery disease

    Article • Lipids in Health and Disease, December 2017, Springer Science + Business Media

    Prof. Maciej Banach

  242. HDL functionality in type 1 diabetes

    Article • Atherosclerosis, December 2017, Elsevier

    Prof. Maciej Banach

  243. Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents

    Article • Current Opinion in Lipidology, December 2017, Wolters Kluwer Health

    Prof. Maciej Banach

  244. Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

    Article • Drugs, November 2017, Springer Science + Business Media

    Prof. Maciej Banach

  245. The impact of argan oil on plasma lipids in humans: Systematic review and meta-analysis of randomized controlled trials

    Article • Phytotherapy Research, November 2017, Wiley

    Prof. Maciej Banach

  246. The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis

    Article • Journal of Clinical Lipidology, November 2017, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  247. The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study

    Article • American Heart Journal, November 2017, Elsevier

    Prof. Maciej Banach

  248. Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans

    Article • Lipids in Health and Disease, October 2017, Springer Science + Business Media

    Prof. Maciej Banach

  249. The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis

    Article • Atherosclerosis, October 2017, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  250. Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials

    Article • Pharmacological Research, October 2017, Elsevier

    Prof. Maciej Banach

  251. C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults

    Article • Angiology, September 2017, SAGE Publications

    Prof. Maciej Banach

  252. Telomere attrition, kidney function, and prevalent chronic kidney disease in the United States

    Article • Oncotarget, September 2017, Impact Journals, LLC

    Prof. Maciej Banach

  253. Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials

    Article • Journal of Diabetes and its Complications, September 2017, Elsevier

    Prof. Maciej Banach

  254. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

    Article • Nutrition Reviews, September 2017, Oxford University Press (OUP)

    Prof. Maciej Banach

  255. Optimizing Cholesterol Treatment in Patients With Muscle Complaints

    Article • Journal of the American College of Cardiology, September 2017, Elsevier

    Prof. Maciej Banach

  256. Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review

    Article • Critical Reviews in Food Science and Nutrition, August 2017, Taylor & Francis

    Prof. Maciej Banach, Professor Peter E. Penson

  257. The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction

    Article • Scientific Reports, August 2017, Springer Science + Business Media

    Prof. Maciej Banach

  258. Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients?

    Article • Current Pharmaceutical Design, August 2017, Bentham Science Publishers

    Prof. Maciej Banach

  259. Usefulness of atherogenic dyslipidemia index to assess the cardiovascular risk of primary care patients – Results from lipidogram 2004 and lipidogram 2006 studies

    Article • Atherosclerosis, August 2017, Elsevier

    Katarzyna Rygiel, Prof. Maciej Banach

  260. Lipids profile and efficacy of treatment of dyslipidemia in primary care in Poland. Results of lipidogram 5 years study (2004–2010)

    Article • Atherosclerosis, August 2017, Elsevier

    Prof. Maciej Banach

  261. The assessment of selected markers of cardiac dysfunction in the analysis of cardiovascular risk in dialysis patients

    Article • Atherosclerosis, August 2017, Elsevier

    Prof. Maciej Banach

  262. The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trials

    Article • Pharmacological Research, August 2017, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  263. Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes

    Article • Journal of Cellular Biochemistry, July 2017, Wiley

    Prof. Maciej Banach

  264. Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis

    Article • Cardiovascular Drugs and Therapy, July 2017, Springer Science + Business Media

    Prof. Maciej Banach

  265. Lipoprotein(a): A missing culprit in the management of athero-thrombosis?

    Article • Journal of Cellular Physiology, July 2017, Wiley

    Prof. Maciej Banach

  266. PCSK9 and infection: A potentially useful or dangerous association?

    Article • Journal of Cellular Physiology, July 2017, Wiley

    Prof. Maciej Banach

  267. Hypertension - Current Natural Strategies to Lower Blood Pressure

    Article • Current Pharmaceutical Design, July 2017, Bentham Science Publishers

    Prof. Maciej Banach

  268. Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia

    Article • Current Pharmaceutical Design, July 2017, Bentham Science Publishers

    Prof. Maciej Banach

  269. The Use of Plant Sterols and Stanols as Lipid-Lowering Agents in Cardiovascular Disease

    Article • Current Pharmaceutical Design, July 2017, Bentham Science Publishers

    Prof. Maciej Banach

  270. Editorial: Natural Products as the Integral Part of the Therapy?

    Article • Current Pharmaceutical Design, July 2017, Bentham Science Publishers

    Prof. Maciej Banach

  271. HDL abnormalities in familial hypercholesterolemia: Focus on biological functions

    Article • Progress in Lipid Research, July 2017, Elsevier

    Prof. Maciej Banach

  272. Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study

    Article • International Journal of Cardiology, July 2017, Elsevier

    Prof. Maciej Banach, Dr. Richard M Allman

  273. Statins, haemostatic factors and thrombotic risk

    Article • Current Opinion in Cardiology, July 2017, Wolters Kluwer Health

    Prof. Maciej Banach

  274. Corrigendum to “Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study” [Int. J. Cardiol. 235 (2017) 11–16]

    Article • International Journal of Cardiology, July 2017, Elsevier

    Prof. Maciej Banach

  275. Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis

    Article • Journal of Clinical Lipidology, July 2017, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  276. Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With HypertensionNovelty and Significance

    Article • Hypertension, June 2017, Wolters Kluwer Health

    Lisandro Colantonio, Prof. Maciej Banach

  277. Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases

    Article • International Journal of Molecular Sciences, June 2017, MDPI AG

    Prof. Maciej Banach

  278. Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of α V β 3 Integrin Activity

    Article • Scientific Reports, June 2017, Springer Science + Business Media

    Prof. Maciej Banach

  279. Telomere Length Is Associated With Cardiometabolic Factors in US Adults

    Article • Angiology, June 2017, SAGE Publications

    Prof. Maciej Banach

  280. Response letter: Management of statin-induced myopathies: Much demands and still (almost) empty hands!

    Article • Journal of Cachexia Sarcopenia and Muscle, June 2017, Wiley

    Prof. Maciej Banach

  281. PCSK9 and diabetes: is there a link?

    Article • Drug Discovery Today, June 2017, Elsevier

    Prof. Maciej Banach

  282. Regulation of PCSK9 by nutraceuticals

    Article • Pharmacological Research, June 2017, Elsevier

    Prof. Maciej Banach

  283. The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis

    Article • Drugs, June 2017, Springer Science + Business Media

    Prof. Maciej Banach, Professor Peter E. Penson

  284. Effects of selected dietary constituents on high-sensitivity C-reactive protein levels in U.S. adults

    Article • Annals of Medicine, May 2017, Taylor & Francis

    Prof. Maciej Banach

  285. MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

    Article • Clinical Reviews in Allergy & Immunology, May 2017, Springer Science + Business Media

    Prof. Maciej Banach

  286. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    Article • New England Journal of Medicine, May 2017, New England Journal of Medicine (NEJM/MMS)

    Prof. Maciej Banach, Professor Thomas Munzel or Muenzel, Assoc. Prof. Elisabeta Badila, Professor Dmitry Zateyshchikov

  287. Hydrophilic vs lipophilic statins in coronary artery disease: A meta-analysis of randomized controlled trials

    Article • Journal of Clinical Lipidology, May 2017, Elsevier

    Professor Deepak L Bhatt, Prof. Maciej Banach

  288. Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease

    Article • Journal of Clinical Lipidology, May 2017, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  289. Effects of curcumin on HDL functionality

    Article • Pharmacological Research, May 2017, Elsevier

    Prof. Maciej Banach

  290. Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study

    Article • International Journal of Cardiology, May 2017, Elsevier

    Prof. Maciej Banach, Dr. Richard M Allman

  291. Accuracy of low-density lipoprotein cholesterol estimation at very low levels

    Article • BMC Medicine, April 2017, Springer Science + Business Media

    Prof. Maciej Banach

  292. The role of nutraceuticals in the prevention of cardiovascular disease

    Article • Cardiovascular Diagnosis and Therapy, April 2017, AME Publishing Company

    Prof. Maciej Banach, Professor Peter E. Penson

  293. PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk

    Article • Current Pharmaceutical Design, March 2017, Bentham Science Publishers

    Prof. Maciej Banach

  294. The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients

    Article • Nephrology Dialysis Transplantation, March 2017, Oxford University Press (OUP)

    Prof. Maciej Banach

  295. Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials

    Article • Nutrition Reviews, March 2017, Oxford University Press (OUP)

    Prof. Maciej Banach

  296. Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

    Article • Cardiovascular Drugs and Therapy, March 2017, Springer Science + Business Media

    Prof. Maciej Banach

  297. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction

    Article • Journal of the American College of Cardiology, March 2017, Elsevier

    Lisandro Colantonio, Prof. Maciej Banach

  298. HYDROPHILIC VERSUS LIPOPHILIC STATINS IN CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Article • Journal of the American College of Cardiology, March 2017, Elsevier

    Professor Deepak L Bhatt, Prof. Maciej Banach

  299. EDOXABAN THERAPY INCREASES TREATMENT SATISFACTION AND REDUCES UTILIZATION OF HEALTH CARE RESOURCES: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY

    Article • Journal of the American College of Cardiology, March 2017, Elsevier

    Prof. Maciej Banach

  300. Are two drugs better than one? A review of combination therapies for hypertension

    Article • Expert Opinion on Pharmacotherapy, February 2017, Taylor & Francis

    Prof. Maciej Banach

  301. The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review

    Article • Lipids in Health and Disease, February 2017, Springer Science + Business Media

    Prof. Maciej Banach

  302. Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials

    Article • BMC Medicine, February 2017, Springer Science + Business Media

    Prof. Maciej Banach

  303. Mineral and vitamins consumption is associated with longer telomeres among US adults

    Article • Polish Archives of Internal Medicine, February 2017, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Prof. Maciej Banach

  304. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence

    Article • Atherosclerosis Supplements, February 2017, Elsevier

    Prof. Maciej Banach

  305. Intensive LDL-cholesterol lowering therapy and neurocognitive function

    Article • Pharmacology & Therapeutics, February 2017, Elsevier

    Prof. Maciej Banach

  306. Novel approaches toward the generation of bioscaffolds as a potential therapy in cardiovascular tissue engineering

    Article • International Journal of Cardiology, February 2017, Elsevier

    Prof. Maciej Banach

  307. Wytyczne PTL/KLRwP/PTK dotyczące postępowania w zaburzeniach lipidowych dla lekarzy rodzinnych 2016

    Article • Kardiologia Polska, January 2017, Polskie Towarzystwo Kardiologiczne

    Prof. Maciej Banach

  308. Evaluating bempedoic acid for the treatment of hyperlipidaemia

    Article • Expert Opinion on Investigational Drugs, January 2017, Taylor & Francis

    Prof. Maciej Banach, Professor Peter E. Penson

  309. Impact of Statin Therapy on Plasma MMP-3, MMP-9, and TIMP-1 Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

    Article • Angiology, January 2017, SAGE Publications

    Prof. Maciej Banach

  310. High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease

    Article • Current Vascular Pharmacology, January 2017, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  311. Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?

    Article • Drug Discovery Today, January 2017, Elsevier

    Prof. Maciej Banach

  312. Association between telomere length and complete blood count in US adults

    Article • Archives of Medical Science, January 2017, Termedia Sp. z.o.o.

    Prof. Maciej Banach, Professor Peter E. Penson

  313. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

    Article • Archives of Medical Science, January 2017, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  314. Lipoprotein(a) and inhibitors of proprotein convertase subtilisin/kexin type 9

    Article • Journal of Thoracic Disease, January 2017, AME Publishing Company

    Prof. Maciej Banach

  315. Physical Exercise and DNA Injury

    Article • January 2017, Elsevier

    Prof. Maciej Banach

  316. PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016

    Article • Archives of Medical Science, January 2017, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  317. The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey

    Article • Archives of Medical Science, January 2017, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  318. Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk

    Article • Archives of Medical Science, January 2017, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  319. PCSK9 inhibitors in sepsis: a new potential indication?

    Article • Expert Opinion on Investigational Drugs, December 2016, Taylor & Francis

    Prof. Maciej Banach

  320. Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

    Article • International Urology and Nephrology, December 2016, Springer Science + Business Media

    Prof. Maciej Banach

  321. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

    Article • Atherosclerosis Supplements, December 2016, Elsevier

    Professor Erkin Mirrakhimov, Prof. Maciej Banach

  322. Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement

    Article • International Journal of Cardiology, December 2016, Elsevier

    Prof. Maciej Banach

  323. D-003 (Saccharum officinarum): The forgotten lipid-lowering agent

    Article • Pharmacological Research, December 2016, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  324. Effects of pentoxifylline on inflammatory markers and blood pressure

    Article • Journal of Hypertension, December 2016, Wolters Kluwer Health

    Prof. Maciej Banach, Professor Peter E. Penson

  325. Lipid-modifying effects of nutraceuticals: An evidence-based approach

    Article • Nutrition, November 2016, Elsevier

    Prof. Maciej Banach

  326. Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies

    Article • International Journal of Cardiology, October 2016, Elsevier

    Prof. Maciej Banach

  327. What is the association of lipid levels and incident stroke?

    Article • International Journal of Cardiology, October 2016, Elsevier

    Prof. Maciej Banach

  328. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms

    Article • Atherosclerosis, October 2016, Elsevier

    Prof. Maciej Banach

  329. Lipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm

    Article • Angiology, September 2016, SAGE Publications

    Professor Maciej Banach, Prof. Maciej Banach

  330. Polypills for the prevention of Cardiovascular diseases

    Article • Expert Opinion on Investigational Drugs, September 2016, Taylor & Francis

    Prof. Maciej Banach

  331. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?

    Article • Journal of Cachexia Sarcopenia and Muscle, September 2016, Wiley

    Prof. Maciej Banach

  332. Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease

    Article • Expert Opinion on Pharmacotherapy, September 2016, Taylor & Francis

    Prof. Maciej Banach

  333. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients

    Article • Pharmacological Research, September 2016, Elsevier

    Prof. Maciej Banach

  334. Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over

    Article • EuroIntervention, September 2016, Europa Digital & Publishing

    Prof. Maciej Banach

  335. A systematic review and meta-analysis comparing the effects of statins and fibrates on plasma lipoprotein(a) levels

    Article • Atherosclerosis, September 2016, Elsevier

    Prof. Maciej Banach

  336. Can the effects of gender, menopause and ageing on lipid levels be differentiated?

    Article • Clinical Endocrinology, August 2016, Wiley

    Prof. Maciej Banach

  337. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations

    Article • Clinical Nutrition, August 2016, Elsevier

    Prof. Maciej Banach

  338. Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis

    Article • Scientific Reports, July 2016, Springer Science + Business Media

    Prof. Maciej Banach

  339. Complex relationship of obesity and obesity paradox in heart failure – higher risk of developing heart failure and better outcomes in established heart failure

    Article • Annals of Medicine, July 2016, Taylor & Francis

    Prof. Maciej Banach

  340. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

    Article • Journal of the American Heart Association, July 2016, Wolters Kluwer Health

    Prof. Maciej Banach

  341. Bioresorbable scaffold — A magic bullet for the treatment of coronary artery disease?

    Article • International Journal of Cardiology, July 2016, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  342. IMPROVE-IT

    Article • Current Opinion in Cardiology, July 2016, Wolters Kluwer Health

    Prof. Maciej Banach

  343. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questions

    Article • Critical Reviews in Clinical Laboratory Sciences, June 2016, Taylor & Francis

    Prof. Maciej Banach, Professor Peter E. Penson

  344. Editorial: MicroRNA-33 Inhibition: A Potential Adjunct to Statin Therapy?

    Article • Current Vascular Pharmacology, June 2016, Bentham Science Publishers

    Prof. Maciej Banach

  345. Expert opinion: the therapeutic challenges faced by statin intolerance

    Article • Expert Opinion on Pharmacotherapy, June 2016, Taylor & Francis

    Prof. Maciej Banach

  346. Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial

    Article • Clinical Nutrition, June 2016, Elsevier

    Prof. Maciej Banach

  347. Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases

    Article • Molecular Diagnosis & Therapy, May 2016, Springer Science + Business Media

    Prof. Maciej Banach

  348. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials

    Article • Pharmacological Research, May 2016, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  349. Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …

    Article • Journal of the American Heart Association, April 2016, Wolters Kluwer Health

    Prof. Maciej Banach

  350. THE EFFECT OF QUERCETIN ON BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Article • Journal of the American College of Cardiology, April 2016, Elsevier

    Prof. Maciej Banach

  351. Rozpowszechnienie zaburzeń lipidowych w Polsce. Wyniki badania NATPOL 2011.

    Article • Kardiologia Polska, March 2016, VM Media SP. zo.o VM Group SK

    Prof. Maciej Banach

  352. Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

    Article • Lipids in Health and Disease, March 2016, Springer Science + Business Media

    Prof. Maciej Banach

  353. The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease

    Article • Current Vascular Pharmacology, March 2016, Bentham Science Publishers

    Prof. Maciej Banach

  354. Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapy

    Article • International Journal of Cardiology, March 2016, Elsevier

    Lisandro Colantonio, Prof. Maciej Banach

  355. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT

    Article • Journal of Hypertension, March 2016, Wolters Kluwer Health

    Prof. Maciej Banach, Professor Yuriy M. Sirenko

  356. Discussion around statin discontinuation in older adults and patients with wasting diseases

    Article • Journal of Cachexia Sarcopenia and Muscle, February 2016, Wiley

    Prof. Maciej Banach

  357. Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

    Article • Lipids in Health and Disease, February 2016, Springer Science + Business Media

    Prof. Maciej Banach

  358. Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients

    Article • Angiology, January 2016, SAGE Publications

    Prof. Maciej Banach

  359. Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate

    Article • BMC Medicine, January 2016, Springer Science + Business Media

    Prof. Maciej Banach

  360. Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials

    Article • Scientific Reports, January 2016, Springer Science + Business Media

    Prof. Maciej Banach

  361. Effect of garlic on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled clinical trials

    Article • Nutrition, January 2016, Elsevier

    Prof. Maciej Banach

  362. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges

    Article • Archives of Medical Science, January 2016, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  363. Complications of Diabetes 2016

    Article • Journal of Diabetes Research, January 2016, Hindawi Publishing Corporation

    Prof. Maciej Banach

  364. Evaluation of medical and psychological parameters of quality of life in supraventricular tachyarrhythmia children. A comparison with healthy children

    Article • Archives of Medical Science, January 2016, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  365. Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis

    Article • Pharmacological Research, January 2016, Elsevier

    Prof. Maciej Banach

  366. Molecular mechanisms of statin intolerance

    Article • Archives of Medical Science, January 2016, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  367. Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients

    Article • Archives of Medical Science, January 2016, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  368. The impact of statin therapy on plasma levels of von Willebrand factor antigen

    Article • Thrombosis and Haemostasis, January 2016, Schattauer GmbH

    Prof. Maciej Banach

  369. Sex-dependent differences in obesity indices and inflammatory markers in non-diabetic obese patients

    Article • Artery Research, December 2015, Elsevier

    Prof. Maciej Banach

  370. Lipids, blood pressure and kidney update 2015

    Article • Lipids in Health and Disease, December 2015, Springer Science + Business Media

    Prof. Maciej Banach

  371. Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options

    Article • Expert Opinion on Pharmacotherapy, November 2015, Informa Healthcare

    Prof. Maciej Banach

  372. Familial hypercholesterolaemia: A global call to arms

    Article • Atherosclerosis, November 2015, Elsevier

    Prof. Maciej Banach

  373. Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials

    Article • Journal of Functional Foods, October 2015, Elsevier

    Prof. Maciej Banach

  374. Impact of anemia treatment with methoxy polyethylene glycol-epoetin beta on polymorphonuclear cells apoptosis in predialysis patients with chronic kidney disease

    Article • Pharmacological Reports, October 2015, Elsevier

    Prof. Maciej Banach

  375. Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

    Article • BMC Medicine, September 2015, Springer Science + Business Media

    Prof. Maciej Banach

  376. An evaluation of RVX-208 for the treatment of atherosclerosis

    Article • Expert Opinion on Investigational Drugs, September 2015, Informa Healthcare

    Prof. Maciej Banach

  377. Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

    Article • Pharmacological Research, September 2015, Elsevier

    Prof. Maciej Banach

  378. Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials

    Article • Nutrition, September 2015, Elsevier

    Prof. Maciej Banach

  379. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study

    Article • Atherosclerosis, September 2015, Elsevier

    Prof. Maciej Banach

  380. Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients

    Article • Atherosclerosis, September 2015, Elsevier

    Prof. Maciej Banach

  381. Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol

    Article • Circulation, August 2015, Wolters Kluwer Health

    Prof. Maciej Banach

  382. Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials

    Article • Atherosclerosis, August 2015, Elsevier

    Prof. Maciej Banach

  383. Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study

    Article • Expert Opinion on Biological Therapy, July 2015, Informa Healthcare

    Prof. Maciej Banach

  384. Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

    Article • Journal of Clinical Lipidology, July 2015, Elsevier

    Prof. Maciej Banach

  385. A systematic review and meta-analysis of the impact of spirulina supplementation on plasma lipid concentrations

    Article • Atherosclerosis, July 2015, Elsevier

    Prof. Maciej Banach

  386. Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials

    Article • Atherosclerosis, July 2015, Elsevier

    Prof. Maciej Banach

  387. Markers of increased cardiovascular risk in elderly patients with chronic kidney disease: A preliminary study

    Article • Atherosclerosis, July 2015, Elsevier

    Prof. Maciej Banach

  388. Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials

    Article • Atherosclerosis, July 2015, Elsevier

    Prof. Maciej Banach

  389. Strength-endurance training may promote pro-atherogenic changes in lipoprotein profile of adolescent rowers

    Article • Atherosclerosis, July 2015, Elsevier

    Prof. Maciej Banach

  390. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Prof. Maciej Banach

  391. Is Blood Pressure Control for Stroke Prevention the Correct Goal?

    Article • Stroke, June 2015, Wolters Kluwer Health

    Prof. Maciej Banach

  392. Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials

    Article • International Journal of Cardiology, June 2015, Elsevier

    Prof. Maciej Banach

  393. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations

    Article • Scientific Reports, May 2015, Springer Science + Business Media

    Prof. Maciej Banach

  394. Sudden cardiac death in CKD patients

    Article • International Urology and Nephrology, May 2015, Springer Science + Business Media

    Prof. Maciej Banach

  395. The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension

    Article • International Journal of Molecular Sciences, May 2015, MDPI AG

    Prof. Maciej Banach

  396. Lipids, blood pressure and kidney update 2014

    Article • Pharmacological Research, May 2015, Elsevier

    Prof. Maciej Banach

  397. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

    Article • Expert Opinion on Drug Safety, April 2015, Informa Healthcare

    Prof. Maciej Banach

  398. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge

    Article • International Urology and Nephrology, March 2015, Springer Science + Business Media

    Prof. Maciej Banach

  399. Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension

    Article • Scientific Reports, March 2015, Springer Science + Business Media

    Prof. Maciej Banach

  400. Renalase is Removed by Kidneys and During Dialysis – Excess Related to CKD Complications?

    Article • Current Vascular Pharmacology, March 2015, Bentham Science Publishers

    Prof. Maciej Banach

  401. In reply—Coenzyme Q10 and Statin-Induced Myopathy

    Article • Mayo Clinic Proceedings, March 2015, Elsevier

    Prof. Maciej Banach

  402. Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2015, Endocrine Society

    Prof. Maciej Banach

  403. Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease

    Article • Expert Opinion on Investigational Drugs, January 2015, Informa Healthcare

    Prof. Maciej Banach

  404. Combination Therapy In Dyslipidemia

    Article • January 2015, Springer Science + Business Media

    Prof. Maciej Banach

  405. Conclusions and Take Home Message

    Article • January 2015, Springer Science + Business Media

    Prof. Maciej Banach

  406. Complications of Diabetes

    Article • Journal of Diabetes Research, January 2015, Hindawi Publishing Corporation

    Prof. Maciej Banach

  407. Statins and Fibrates: Should They Be Recommended?

    Article • January 2015, Springer Science + Business Media

    Prof. Maciej Banach

  408. Letter to the Editor Dysfunctional high-density lipoprotein: not only quantity but first of all quality?

    Article • Archives of Medical Science, January 2015, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  409. Wpływ statyn na majaczenie w następstwie operacji kardiochirurgicznych – dowody z piśmiennictwa

    Article • Psychiatria Polska, January 2015, Komitet Redakcyjno - Wydawniczy Polskiego Towarzystwa Psychiatrycznego

    Prof. Maciej Banach

  410. Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 patients

    Article • International Journal of Cardiology, January 2015, Elsevier

    Prof. Maciej Banach

  411. Association between statin use and plasma D-dimer levels

    Article • Thrombosis and Haemostasis, January 2015, Schattauer GmbH

    Prof. Maciej Banach

  412. Effects of Coenzyme Q10 on Statin-Induced Myopathy

    Article • Mayo Clinic Proceedings, January 2015, Elsevier

    Prof. Maciej Banach

  413. Systematic review/Meta-analysis Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials

    Article • Archives of Medical Science, January 2015, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  414. Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

    Article • Archives of Medical Science, January 2015, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  415. The influence of hypoxic physical activity on cfDNA as a new marker of vascular inflammation

    Article • Archives of Medical Science, January 2015, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  416. Club 35 Poster session 3: Friday 5 December 2014, 08:30-18:00 * Location: Poster area

    Article • European Heart Journal - Cardiovascular Imaging, December 2014, European Society of Cardiology

    Professor Valentina Kutyifa, Prof. Maciej Banach

  417. Effects of Established Hypolipidemic Drugs on HDL Concentration, Subclass Distribution, and Function

    Article • December 2014, Springer Science + Business Media

    Prof. Maciej Banach

  418. ETC-1002: A future option for lipid disorders?

    Article • Atherosclerosis, December 2014, Elsevier

    Prof. Maciej Banach

  419. Contrasting Cholesterol Management Guidelines for Adults with CKD

    Article • Journal of the American Society of Nephrology, November 2014, American Society of Nephrology

    Lisandro Colantonio, Prof. Maciej Banach

  420. Red blood cell transfusion is a determinant of neurological complications after cardiac surgery

    Article • Interactive Cardiovascular and Thoracic Surgery, November 2014, Oxford University Press (OUP)

    Prof. Maciej Banach

  421. Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication

    Article • International Journal of Cardiology, September 2014, Elsevier

    Prof. Maciej Banach

  422. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient

    Article • Journal of Hypertension, September 2014, Wolters Kluwer Health

    Prof. Maciej Banach, Professor Yuriy M. Sirenko

  423. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline

    Article • Journal of Hypertension, September 2014, Wolters Kluwer Health

    Prof. Maciej Banach, Professor Yuriy M. Sirenko

  424. Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation

    Article • Current Pharmaceutical Design, August 2014, Bentham Science Publishers

    Prof. Maciej Banach

  425. Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?

    Article • Current Medicinal Chemistry, July 2014, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  426. Can We Change the Functionality of HDL Cholesterol with Nonpharmacological and Pharmacological Agents?

    Article • Current Medicinal Chemistry, July 2014, Bentham Science Publishers

    Maria-Corina Serban, Prof. Maciej Banach

  427. Subfractions and Subpopulations of HDL: An Update

    Article • Current Medicinal Chemistry, July 2014, Bentham Science Publishers

    Prof. Maciej Banach

  428. Editorial (Thematic Issue: Current Research, Knowledge and Controversies on High Density Lipoprotein)

    Article • Current Medicinal Chemistry, July 2014, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  429. Pre-CKD- Do we Need Another Hero?

    Article • Current Vascular Pharmacology, July 2014, Bentham Science Publishers

    Prof. Maciej Banach

  430. Patients with Prehypertension – Do we have Enough Evidence to Treat them?

    Article • Current Vascular Pharmacology, July 2014, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  431. Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge)

    Article • Current Vascular Pharmacology, July 2014, Bentham Science Publishers

    Prof. Maciej Banach

  432. Influence of exercise training on T-wave alternans assessed during exercise test in heart failure patients

    Article • International Journal of Cardiology, July 2014, Elsevier

    Prof. Maciej Banach

  433. Proprotein Convertase Subtilisin/Kexin 9 Inhibitors

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, June 2014, SAGE Publications

    Prof. Maciej Banach

  434. Statins and New-Onset Diabetes

    Article • Current Pharmaceutical Design, June 2014, Bentham Science Publishers

    Prof. Maciej Banach

  435. Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease

    Article • Drugs, June 2014, Springer Science + Business Media

    Prof. Maciej Banach

  436. Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, June 2014, Elsevier

    Prof. Maciej Banach

  437. Should low high-density lipoprotein cholesterol (HDL-C) be treated?

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, June 2014, Elsevier

    Prof. Maciej Banach

  438. The effect of timing of cardiac catheterization on acute kidney injury after cardiac surgery is influenced by the type of operation

    Article • International Journal of Cardiology, April 2014, Elsevier

    Prof. Maciej Banach

  439. Novel anti-obesity drugs and plasma lipids

    Article • Clinical Lipidology, April 2014, Future Medicine

    Prof. Maciej Banach

  440. Bedside Tool for Predicting the Risk of Postoperative Atrial Fibrillation After Cardiac Surgery: The POAF Score

    Article • Journal of the American Heart Association, March 2014, Wolters Kluwer Health

    Prof. Maciej Banach

  441. Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum

    Article • Journal of Clinical Lipidology, March 2014, Elsevier

    Prof. Maciej Banach

  442. Lipid, blood pressure and kidney update 2013

    Article • International Urology and Nephrology, February 2014, Springer Science + Business Media

    Prof. Maciej Banach

  443. Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level

    Article • Acta Diabetologica, February 2014, Springer Science + Business Media

    Prof. Maciej Banach

  444. Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study

    Article • Lipids in Health and Disease, February 2014, Springer Science + Business Media

    Prof. Maciej Banach

  445. Dysfunctional HDL: the journey from savior to slayer

    Article • Clinical Lipidology, February 2014, Future Medicine

    Prof. Maciej Banach

  446. Editorial: Atrial Fibrillation after Coronary Surgery: The Need for an Effective Pharmacological Prophylaxis

    Article • Current Vascular Pharmacology, January 2014, Bentham Science Publishers

    Prof. Maciej Banach

  447. Hypertension and Prevention of Diastolic Heart Failure in the Aging Population

    Article • January 2014, Springer Science + Business Media

    Professor Maciej Banach, Prof. Maciej Banach

  448. Heart function disturbances in chronic kidney disease – echocardiographic indices

    Article • Archives of Medical Science, January 2014, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  449. Assessment of the Relationship between Lipid Parameters and Obesity Indices in Non-Diabetic Obese Patients: A Preliminary Report

    Article • Medical Science Monitor, January 2014, International Scientific Literature

    Prof. Maciej Banach

  450. Aging and Heart Failure

    Article • January 2014, Springer Science + Business Media

    Prof. Maciej Banach

  451. Markers of increased cardiovascular risk in patients with chronic kidney disease

    Article • Lipids in Health and Disease, January 2014, Springer Science + Business Media

    Prof. Maciej Banach

  452. Heart remodeling induced by adjuvant trastuzumab-containing chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2: A prospective study

    Article • Pharmacological Research, December 2013, Elsevier

    Prof. Maciej Banach

  453. Factors influencing post-coronary artery bypass grafting atrial fibrillation episodes

    Article • Kardiologia Polska, November 2013, VM Media SP. zo.o VM Group SK

    Prof. Maciej Banach

  454. Stanowisko dotyczące postępowania w rodzinnej hipercholesterolemii u dzieci i młodzieży. Stanowisko Forum Ekspertów Lipidowych

    Article • Pediatria Polska, November 2013, Elsevier

    Prof. Maciej Banach

  455. Blood Pressure Levels and Stroke: J-curve Phenomenon?

    Article • Current Hypertension Reports, October 2013, Springer Science + Business Media

    Professor Maciej Banach, Prof. Maciej Banach

  456. Effect of Atorvastatin on Low-Density Lipoprotein Subpopulations and Comparison Between Indicators of Plasma Atherogenicity

    Article • Angiology, October 2013, SAGE Publications

    Prof. Maciej Banach

  457. Postępowanie w rodzinnej hipercholesterolemii u dzieci i młodzieży. Stanowisko Forum Ekspertów Lipidowych

    Article • Kardiologia Polska, October 2013, VM Media SP. zo.o VM Group SK

    Prof. Maciej Banach

  458. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?

    Article • International Journal of Cardiology, October 2013, Elsevier

    Prof. Maciej Banach

  459. Heart failure biomarkers in patients with dilated cardiomyopathy

    Article • International Journal of Cardiology, October 2013, Elsevier

    Prof. Maciej Banach

  460. Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events

    Article • International Journal of Cardiology, October 2013, Elsevier

    Prof. Maciej Banach, Dr. Richard M Allman

  461. Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation

    Article • The American Journal of Medicine, October 2013, Elsevier

    Prof. Maciej Banach

  462. The effects of statins on blood pressure in normotensive or hypertensive subjects — A meta-analysis of randomized controlled trials

    Article • International Journal of Cardiology, October 2013, Elsevier

    Prof. Maciej Banach

  463. Rationale of Statin Therapy in Septic Patients

    Article • Current Vascular Pharmacology, August 2013, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  464. Acute Coronary Syndromes in Patients with Chronic Kidney Disease

    Article • Current Vascular Pharmacology, August 2013, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  465. Statins in patients with chronic kidney disease – an attempt at recommendations

    Article • Current Medical Research and Opinion, August 2013, Informa Healthcare

    Prof. Maciej Banach

  466. Medication Management of Chronic Heart Failure in Older Adults

    Article • Drugs & Aging, August 2013, Springer Science + Business Media

    Prof. Maciej Banach

  467. Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

    Article • Integrated Blood Pressure Control, July 2013, Taylor & Francis

    Professor Maciej Banach, Prof. Maciej Banach

  468. Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance

    Article • Current Pharmaceutical Design, June 2013, Bentham Science Publishers

    Prof. Maciej Banach

  469. Letter on ‘Sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney’

    Article • Journal of Hypertension, June 2013, Wolters Kluwer Health

    Prof. Maciej Banach

  470. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy—A meta-analysis of 11 randomized controlled trials involving 21,295 participants

    Article • Pharmacological Research, June 2013, Elsevier

    Prof. Maciej Banach

  471. The Knowledge and Awareness of Hypertension Among Patients With Hypertension in Central Poland

    Article • Angiology, May 2013, SAGE Publications

    Prof. Maciej Banach

  472. New Obesity Indices and Adipokines in Normotensive Patients and Patients With Hypertension

    Article • Angiology, May 2013, SAGE Publications

    Prof. Maciej Banach

  473. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum

    Article • Journal of Clinical Lipidology, May 2013, Elsevier

    Prof. Maciej Banach

  474. Statin therapy and new-onset diabetes: an attempt at recommendations

    Article • Expert Review of Endocrinology & Metabolism, May 2013, Taylor & Francis

    Prof. Maciej Banach

  475. The Role of Fibrate Treatment in Dyslipidemia: An Overview

    Article • Current Pharmaceutical Design, April 2013, Bentham Science Publishers

    Prof. Maciej Banach

  476. Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

    Article • Current Pharmaceutical Design, April 2013, Bentham Science Publishers

    Prof. Maciej Banach

  477. Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?

    Article • Current Pharmaceutical Design, April 2013, Bentham Science Publishers

    Prof. Maciej Banach

  478. PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?

    Article • Current Pharmaceutical Design, April 2013, Bentham Science Publishers

    Prof. Maciej Banach

  479. Metabolic syndrome and renal disease

    Article • International Journal of Cardiology, April 2013, Elsevier

    Prof. Maciej Banach

  480. The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspective

    Article • Clinical Lipidology, April 2013, Future Medicine

    Prof. Maciej Banach

  481. The risk of atherosclerosis in patients with chronic kidney disease

    Article • International Urology and Nephrology, March 2013, Springer Science + Business Media

    Prof. Maciej Banach

  482. Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials

    Article • Current Medical Research and Opinion, March 2013, Informa Healthcare

    Prof. Maciej Banach

  483. Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease

    Article • Medical Science Monitor, January 2013, International Scientific Literature

    Prof. Maciej Banach

  484. Editorial Statin treatment in the elderly: how much do we know?

    Article • Archives of Medical Science, January 2013, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  485. Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease

    Article • Medical Science Monitor, January 2013, International Scientific Literature

    Prof. Maciej Banach

  486. State of the art paper Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology

    Article • Archives of Medical Science, January 2013, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  487. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology

    Article • International Journal of Cardiology, January 2013, Elsevier

    Prof. Maciej Banach

  488. The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up

    Article • Lipids in Health and Disease, January 2013, Springer Science + Business Media

    Prof. Maciej Banach

  489. State of the art paper Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease

    Article • Archives of Medical Science, January 2013, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  490. Predictors of Insulin Resistance in Patients With Obesity

    Article • Angiology, December 2012, SAGE Publications

    Prof. Maciej Banach

  491. Prevention of sudden cardiac death in patients with chronic kidney disease

    Article • BMC Nephrology, December 2012, Springer Science + Business Media

    Prof. Maciej Banach

  492. Blood Pressure J-Curve: Current Concepts

    Article • Current Hypertension Reports, October 2012, Springer Science + Business Media

    Professor Maciej Banach, Prof. Maciej Banach

  493. Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?

    Article • Progress in Lipid Research, October 2012, Elsevier

    Prof. Maciej Banach

  494. Renalase, Hypertension, and Kidney — The Discussion Continues

    Article • Angiology, September 2012, SAGE Publications

    Prof. Maciej Banach

  495. An update on biomarkers of heart failure in hypertensive patients

    Article • Journal of Hypertension, September 2012, Wolters Kluwer Health

    Prof. Maciej Banach

  496. Observations on Degenerative Changes Within the Optic Nerve in Patients With Primary Open Glaucoma and Arterial Hypertension: 6-Month Follow-Up

    Article • Journal of Clinical Hypertension, August 2012, Wiley

    Prof. Maciej Banach

  497. Lipids, Blood Pressure, Kidney-what was New in 2012?

    Article • International Journal of Pharmacology, August 2012, Science Alert

    Prof. Maciej Banach

  498. Statins and the Risk of Diabetes: The Debate

    Article • Archives of Internal Medicine, June 2012, American Medical Association (AMA)

    Professor Maciej Banach, Prof. Maciej Banach

  499. Statin use and risk of diabetes mellitus in postmenopausal women

    Article • Clinical Lipidology, June 2012, Taylor & Francis

    Professor Maciej Banach, Prof. Maciej Banach

  500. The meaning of hypokalemia in heart failure

    Article • International Journal of Cardiology, June 2012, Elsevier

    Prof. Maciej Banach

  501. Preoperative Statin Therapy Is Not Associated With a Decrease in the Incidence of Delirium After Cardiac Operations

    Article • The Annals of Thoracic Surgery, May 2012, Elsevier

    Prof. Maciej Banach

  502. Hypertension therapy in the older adults—do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly

    Article • Journal of Human Hypertension, April 2012, Springer Science + Business Media

    Prof. Maciej Banach

  503. Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults

    Article • Annals of Medicine, March 2012, Taylor & Francis

    Prof. Maciej Banach

  504. Hypertension and kidney disease

    Article • Journal of Hypertension, March 2012, Wolters Kluwer Health

    Prof. Maciej Banach

  505. Polish Lipid Association – A strong response to the problem of lipid disorders in Poland and Central and Eastern Europe

    Article • Journal of Clinical Lipidology, March 2012, Elsevier

    Prof. Maciej Banach

  506. Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients

    Article • International Journal of Cardiology, February 2012, Elsevier

    Prof. Maciej Banach

  507. Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 – a prospective study

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  508. Editorial Lipid-lowering therapies and achievement of LDL-cholesterol targets

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  509. Editorial The effects of statins on blood pressure: current knowledge and future perspectives

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  510. Association between heart rate at rest and myocardial perfusion in patients with acute myocardial infarction undergoing cardiac rehabilitation – a pilot study

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Dr Kihei Yoneyama, Prof. Maciej Banach

  511. Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels

    Article • Journal of Hypertension, December 2011, Wolters Kluwer Health

    Prof. Maciej Banach

  512. Imbalance between pro-angiogenic and anti-angiogenic factors in rheumatic and mixomatous mitral valves

    Article • International Journal of Cardiology, November 2011, Elsevier

    Prof. Maciej Banach

  513. Ten most important things to learn from the ACCF/AHA 2011 expert consensus document on hypertension in the elderly

    Article • Blood Pressure, October 2011, Taylor & Francis

    Prof. Maciej Banach

  514. Left atrial size in hypertension and stroke

    Article • Journal of Hypertension, October 2011, Wolters Kluwer Health

    Prof. Maciej Banach

  515. Statins – Do we really know all mechanisms of action of this group of drugs?

    Article • Chemistry and Physics of Lipids, August 2011, Elsevier

    Prof. Maciej Banach

  516. What is the risk of hyperkalaemia in heart failure?

    Article • Expert Opinion on Pharmacotherapy, July 2011, Informa Healthcare

    Prof. Maciej Banach

  517. Dronedarone: An overview

    Article • Annals of Medicine, July 2011, Taylor & Francis

    Prof. Maciej Banach

  518. Correlation of the severity of diabetic retinopathy and the heart muscle perfusion in patients with type 2 diabetes

    Article • Journal of Diabetes and its Complications, July 2011, Elsevier

    Prof. Maciej Banach

  519. Ventricular Assist Device – How to Obtain Optimal Benefits?

    Article • April 2011, IntechOpen

    Professor Maciej Banach, Prof. Maciej Banach

  520. What should be the optimal levels of blood pressure: does the J-curve phenomenon really exist?

    Article • Expert Opinion on Pharmacotherapy, April 2011, Informa Healthcare

    Prof. Maciej Banach

  521. Gender Differences in the Treatment of Ischemic Heart Disease

    Article • Current Pharmaceutical Design, April 2011, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  522. Relation of Baseline Systolic Blood Pressure and Long-Term Outcomes in Ambulatory Patients With Chronic Mild to Moderate Heart Failure

    Article • The American Journal of Cardiology, April 2011, Elsevier

    Prof. Maciej Banach

  523. Reply to Preoperative n-3 Polyunsatured Fatty Acids Do Not Reduce Postoperative Atrial Fibrillation in Cardiac Surgery, by Takagi I. and Umemoto T

    Article • Angiology, March 2011, SAGE Publications

    Prof. Maciej Banach

  524. Malignancy-Associated Dyslipidemia

    Article • The Open Cardiovascular Medicine Journal, February 2011, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  525. The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe

    Article • Current Cardiovascular Risk Reports, January 2011, Springer Science + Business Media

    Prof. Maciej Banach

  526. Statins and dilated cardiomyopathy: do we have enough data?

    Article • Expert Opinion on Investigational Drugs, January 2011, Informa Healthcare

    Prof. Maciej Banach

  527. Erythropoietin update 2011

    Article • Medical Science Monitor, January 2011, International Scientific Literature

    Professor Maciej Banach, Prof. Maciej Banach

  528. State of the art papers Lipids, blood pressure, kidney – what was new in 2011?

    Article • Archives of Medical Science, January 2011, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  529. Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease

    Article • Journal of Nephrology, January 2011, Wichtig

    Prof. Maciej Banach

  530. Optimal Timing of Discontinuation of Clopidogrel and Risk of Blood Transfusion After Coronary Surgery

    Article • Circulation Journal, January 2011, Japanese Circulation Society

    Prof. Maciej Banach

  531. Prognostic value of plasma N-terminal pro-B-type natriuretic peptide concentration in patients with normal and impaired left ventricular systolic function undergoing surgery for abdominal aortic aneurysm

    Article • Archives of Medical Science, January 2011, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  532. Relevance of 123 I-BMIPP delayed scintigraphic imaging for patients with angina pectoris – a pilot study

    Article • Archives of Medical Science, January 2011, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  533. Editorial [Hot topic: Controversies in Hypertension Treatment (Guest Editors: Maciej Banach, Sverre E. Kjeldsen and Krzysztof Narkiewicz)]

    Article • Current Vascular Pharmacology, November 2010, Bentham Science Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  534. Current Place of Beta-Blockers in the Treatment of Hypertension

    Article • Current Vascular Pharmacology, November 2010, Bentham Science Publishers

    Prof. Maciej Banach

  535. Clinical Implications of Non-Invasive Measurement of Central Aortic Blood Pressure

    Article • Current Vascular Pharmacology, November 2010, Bentham Science Publishers

    Prof. Maciej Banach

  536. The Use of DSM-IV and ICD-10 Criteria and Diagnostic Scales for Delirium Among Cardiac Surgery Patients: Results From the IPDACS Study

    Article • Journal of Neuropsychiatry, October 2010, American Psychiatric Association

    Prof. Maciej Banach

  537. Current problems in hypertension and nephrology

    Article • Expert Opinion on Pharmacotherapy, October 2010, Informa Healthcare

    Professor Maciej Banach, Prof. Maciej Banach

  538. Statins in patients with chronic kidney disease: why, who and when?

    Article • Expert Opinion on Pharmacotherapy, October 2010, Informa Healthcare

    Prof. Maciej Banach

  539. Incidence and predictors of delirium after cardiac surgery: Results from The IPDACS Study

    Article • Journal of Psychosomatic Research, August 2010, Elsevier

    Prof. Maciej Banach

  540. Morphine-mediated alteration of hypertension-related gene expression in human white blood cells and multilineage progenitor cells

    Article • Journal of Human Hypertension, July 2010, Springer Science + Business Media

    Prof. Maciej Banach

  541. Postoperative Atrial Fibrillation - What Do We Really Know?

    Article • Current Vascular Pharmacology, July 2010, Bentham Science Publishers

    Prof. Maciej Banach

  542. Takotsubo cardiomyopathy — The current state of knowledge

    Article • International Journal of Cardiology, July 2010, Elsevier

    Prof. Maciej Banach

  543. Angiotensin converting-enzyme inhibitors and candesartan have no effects on atrial fibrillation after cardiac surgery

    Article • International Journal of Cardiology, July 2010, Elsevier

    Prof. Maciej Banach

  544. Impact of Baseline Systolic Blood Pressure on Long-Term Outcomes in Patients With Advanced Chronic Systolic Heart Failure (Insights from the BEST Trial)

    Article • The American Journal of Cardiology, July 2010, Elsevier

    Prof. Maciej Banach

  545. Levosimendan - a calcium sensitising agent with potential anti-arrhythmic properties

    Article • International Journal of Clinical Practice, June 2010, Wiley

    Prof. Maciej Banach

  546. Preoperative n-3 Polyunsatured Fatty Acids Are Associated With a Decrease in the Incidence of Early Atrial Fibrillation Following Cardiac Surgery

    Article • Angiology, June 2010, SAGE Publications

    Prof. Maciej Banach

  547. The role of Toll-like receptors in renal diseases

    Article • Nature Reviews Nephrology, February 2010, Nature

    Prof. Maciej Banach

  548. Are Polymorphisms within Endothelial Nitric Oxide Synthase Good Predictors of Coronary Artery Disease

    Article • Cardiology, January 2010, Karger Publishers

    Professor Maciej Banach, Prof. Maciej Banach

  549. Left atrial and left atrial appendage systolic function in patients with post-myocardial distal blocks

    Article • Archives of Medical Science, January 2010, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  550. Editorial Are we getting to lipid targets in real life?

    Article • Archives of Medical Science, January 2010, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  551. Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study

    Article • Archives of Medical Science, January 2010, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  552. Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study

    Article • Lipids in Health and Disease, January 2010, Springer Science + Business Media

    Prof. Maciej Banach

  553. Progression of diabetic retinopathy correlated with muscle perfusion disturbances of the lower limbs, with clinically important diagnostic recommendations

    Article • Archives of Medical Science, January 2010, Termedia Sp. z.o.o.

    Prof. Maciej Banach

  554. Statin therapy in the elderly: A review

    Article • Archives of Gerontology and Geriatrics, January 2010, Elsevier

    Prof. Maciej Banach

  555. Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis

    Article • International Urology and Nephrology, December 2009, Springer Science + Business Media

    Prof. Maciej Banach

  556. Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery

    Article • Circulation Arrhythmia and Electrophysiology, December 2009, Wolters Kluwer Health

    Prof. Maciej Banach

  557. Vernakalant hydrochloride for the treatment of atrial fibrillation

    Article • Expert Opinion on Investigational Drugs, November 2009, Informa Healthcare

    Prof. Maciej Banach

  558. The Role of Polymorphisms Within Paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the Modulation of Cardiovascular Risk: A Pilot Study

    Article • Angiology, November 2009, SAGE Publications

    Prof. Maciej Banach

  559. Natriuretic Peptides in Septic Patients

    Article • Current Medicinal Chemistry, October 2009, Bentham Science Publishers

    Prof. Maciej Banach

  560. Predictive factors for endoleaks after thoracic aortic aneurysm endograft repair

    Article • Journal of Thoracic and Cardiovascular Surgery, October 2009, Elsevier

    Prof. Maciej Banach

  561. Lone atrial fibrillation: what do we know?

    Article • Heart, August 2009, BMJ

    Prof. Maciej Banach

  562. Role and significance of statins in the treatment of hypertensive patients

    Article • Current Medical Research and Opinion, June 2009, Informa Healthcare

    Prof. Maciej Banach

  563. Is Polymorphism Within eNOS Gene Associated With the Late Onset of Myocardial Infarction? A Pilot Study

    Article • Angiology, June 2009, SAGE Publications

    Prof. Maciej Banach

  564. Percutaneous Coronary Interventions Affect Concentrations of Interleukin 6 and Its Soluble Receptors in Coronary Sinus Blood in Patients With Stable Angina

    Article • Angiology, June 2009, SAGE Publications

    Prof. Maciej Banach

  565. The Clinical Manifestation of Myocardial Infarction in Elderly Patients

    Article • Clinical Cardiology, April 2009, Wiley

    Professor Maciej Banach, Prof. Maciej Banach

  566. Nephroprotective and clinical potential of statins in dialyzed patients

    Article • Expert Opinion on Therapeutic Targets, April 2009, Informa Healthcare

    Prof. Maciej Banach

  567. The mechanisms of atrial fibrillation in hyperthyroidism

    Article • Thyroid Research, April 2009, Springer Science + Business Media

    Prof. Maciej Banach

  568. Atrial Fibrillation: The New Epidemic of the Ageing World

    Article • Journal of Atrial Fibrillation, April 2009, Cardiofront, LLC

    Professor Maciej Banach, Prof. Maciej Banach

  569. HSP 70 and atherosclerosis – protector or activator?

    Article • Expert Opinion on Therapeutic Targets, March 2009, Informa Healthcare

    Prof. Maciej Banach

  570. Aortic stiffness in diabetes mellitus – association with glutamine and heat shock protein 70 expression: a pilot study based on an experimental rodent model

    Article • Expert Opinion on Therapeutic Targets, March 2009, Informa Healthcare

    Prof. Maciej Banach

  571. Arteriovenous Fistula Leading to Severe Tortuosity and Aneurysm Formation

    Article • Journal of Cardiac Surgery, March 2009, Wiley

    Prof. Maciej Banach

  572. The concentration of uric acid in patients with metabolic syndrome and cardiovascular diseases

    Article • Open Medicine, January 2009, De Gruyter

    Prof. Maciej Banach

  573. Endothelial Dysfunction in Patients with Noncomplicated and Complicated Hypertension

    Article • Clinical and Experimental Hypertension, January 2009, Taylor & Francis

    Prof. Maciej Banach

  574. Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival

    Article • Circulation, October 2008, Wolters Kluwer Health

    Prof. Maciej Banach

  575. The Role of Trimetazidine After Acute Myocardial Infarction

    Article • Current Vascular Pharmacology, October 2008, Bentham Science Publishers

    Professor Maciej Banach, Professor Giuseppe M C Rosano, Prof. Maciej Banach

  576. Effects of Atorvastatin on Vascular Intimal Hyperplasia: An Experimental Rodent Model

    Article • Angiology, September 2008, SAGE Publications

    Prof. Maciej Banach

  577. Detection of infectious agents by polymerase chain reaction in human aortic wall

    Article • Cardiovascular Pathology, September 2008, Elsevier

    Prof. Maciej Banach

  578. Papaverine solution improves preservation of saphenous vein grafts used during cardiac surgery

    Article • Acta Cardiologica, August 2008, Peeters Publishers

    Prof. Maciej Banach

  579. The significance of preoperative atrial fibrillation in patients undergoing cardiac surgery: preoperative atrial fibrillation--still underestimated opponent

    Article • EP Europace, August 2008, European Society of Cardiology

    Prof. Maciej Banach

  580. Dofetilide for the Prevention of Postoperative Atrial Fibrillation After Coronary Surgery: Is It a Useful Routine Prophylaxis?

    Article • The American Journal of Cardiology, August 2008, Elsevier

    Prof. Maciej Banach

  581. Obesity and postoperative atrial fibrillation. Is there no connection?

    Article • American Heart Journal, July 2008, Elsevier

    Prof. Maciej Banach

  582. Statins in the prevention of postoperative atrial fibrillation: Is there really no effect?

    Article • American Heart Journal, June 2008, Elsevier

    Prof. Maciej Banach

  583. Endovascular treatment of mycotic aortic aneurysms

    Article • Journal of Thoracic and Cardiovascular Surgery, June 2008, Elsevier

    Prof. Maciej Banach

  584. Plasma Total Antioxidant Activity in Comparison With Plasma NO and VEGF Levels in Patients With Metabolic Syndrome

    Article • Angiology, May 2008, SAGE Publications

    Prof. Maciej Banach

  585. Does Gender Influence the Patency of Infrainguinal Bypass Grafts?

    Article • Angiology, May 2008, SAGE Publications

    Prof. Maciej Banach

  586. LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN SUBJECTS WITH METABOLIC SYNDROME

    Article • Atherosclerosis Supplements, May 2008, Elsevier

    Prof. Maciej Banach

  587. Effect of Cardiovascular Drugs on Adenosine Deaminase Activity

    Article • Angiology, April 2008, SAGE Publications

    Prof. Maciej Banach

  588. Relation Between Postoperative Mortality and Atrial Fibrillation Before Surgical Revascularization - 3-Year Follow-Up

    Article • The Thoracic and Cardiovascular Surgeon, February 2008, Thieme Publishing Group

    Prof. Maciej Banach

  589. Letter by Banach et al Regarding Article, "Postoperative Treatment With Carvedilol, a β-Adrenergic Blocker, Prevents Paroxysmal Atrial Fibrillation After Coronary Artery Bypass Grafting"

    Article • Circulation Journal, January 2008, Japanese Circulation Society

    Professor Maciej Banach, Prof. Maciej Banach

  590. Natriuretic peptides in cardiovascular diseases

    Article • Cellular & Molecular Biology Letters, January 2008, De Gruyter

    Professor Maciej Banach, Prof. Maciej Banach

  591. Carvedilol modifies antioxidant status of patients with stable angina

    Article • Cellular & Molecular Biology Letters, January 2008, De Gruyter

    Prof. Maciej Banach

  592. Clinical Utility and Use of DSM–IV and ICD–10 Criteria and The Memorial Delirium Assessment Scale in Establishing a Diagnosis of Delirium After Cardiac Surgery

    Article • Psychosomatics, January 2008, Elsevier

    Prof. Maciej Banach

  593. Comparison of Transperitoneal and Retroperitoneal Approaches in Abdominal Aortic Surgery

    Article • Acta Chirurgica Belgica, January 2008, Taylor & Francis

    Prof. Maciej Banach

  594. eComment: The anastomosis between aorta and extension conduit of the pulmonary artery

    Article • Interactive Cardiovascular and Thoracic Surgery, December 2007, Oxford University Press (OUP)

    Prof. Maciej Banach

  595. Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, December 2007, Elsevier

    Prof. Maciej Banach

  596. Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement

    Article • Journal of Thoracic and Cardiovascular Surgery, December 2007, Elsevier

    Prof. Maciej Banach

  597. Evaluation of selected parameters of the antioxidative system in patients with type 2 diabetes in different periods of metabolic compensation

    Article • Archivum Immunologiae et Therapiae Experimentalis, October 2007, Springer Science + Business Media

    Prof. Maciej Banach

  598. Echocardiographic Evaluation of the Left Atrium and Left Atrial Appendage Function in Patients with Atrial Septum Aneurysm - Implications for Thromboembolic Complications

    Article • The Thoracic and Cardiovascular Surgeon, September 2007, Thieme Publishing Group

    Prof. Maciej Banach

  599. Plasma Endothelin-1 Levels in Septic Patients

    Article • Journal of Intensive Care Medicine, July 2007, SAGE Publications

    Prof. Maciej Banach

  600. 92 Low BMI as an independent risk factor of death in patients with severe heart failure subjected to aortic valve replacement

    Article • European Journal of Heart Failure Supplements, June 2007, Oxford University Press (OUP)

    Prof. Maciej Banach

  601. Atrial and Brain Natriuretic Peptide and Endothelin-1 Concentration in Patients with Idiopathic Arterial Hypertension: The Dependence on the Selected Morphological Parameters

    Article • Clinical and Experimental Hypertension, January 2007, Taylor & Francis

    Prof. Maciej Banach

  602. N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients

    Article • Cellular & Molecular Biology Letters, January 2007, De Gruyter

    Prof. Maciej Banach

  603. Preoperative predictors of delirium after cardiac surgery: a preliminary study

    Article • General Hospital Psychiatry, November 2006, Elsevier

    Professor Maciej Banach, Prof. Maciej Banach

  604. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment

    Article • Archivum Immunologiae et Therapiae Experimentalis, October 2006, Springer Science + Business Media

    Prof. Maciej Banach

  605. N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE LEVELS CORRELATE WITH PROCALCITONIN AND C-REACTIVE PROTEIN LEVELS IN SEPTIC PATIENTS

    Article • Shock, October 2006, Wolters Kluwer Health

    Prof. Maciej Banach

  606. Neutrophil Superoxide Anion Generation During Atorvastatin and Fluvastatin Therapy Used in Coronary Heart Disease Primary Prevention

    Article • Journal of Cardiovascular Pharmacology, October 2006, Wolters Kluwer Health

    Prof. Maciej Banach

  607. Risk Factors for Atrial Fibrillation in Adult Patients in Long-Term Observation Following Surgical Closure of Atrial Septal Defect Type II

    Article • The Thoracic and Cardiovascular Surgeon, June 2006, Thieme Publishing Group

    Prof. Maciej Banach

  608. TNF-α priming effect on polymorphonuclear leukocyte reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients

    Article • Archivum Immunologiae et Therapiae Experimentalis, May 2006, Springer Science + Business Media

    Prof. Maciej Banach

  609. P3-49

    Article • Heart Rhythm, May 2006, Elsevier

    Professor Pawel Ptaszynski, Prof. Maciej Banach

  610. Risk Factors of Atrial Fibrillation Following Coronary Artery Bypass Grafting

    Article • Circulation Journal, January 2006, Japanese Circulation Society

    Prof. Maciej Banach

  611. Increased Levels of Soluble TNF-α Receptors and Cellular Adhesion Molecules in Patients Undergoing Bioincompatible Hemodialysis

    Article • American Journal of Nephrology, January 2006, Karger Publishers

    Prof. Maciej Banach